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AbstrAct
BACKGROUND: patient adherence to tuberculosis (tb) treatment continues to be problematic 
despite the wide implementation of directly observed therapy (Dot). in many settings with high 
hiv and tb co-infection, the two diseases continue to be treated differently: antiretroviral (aRv) 
programmes often use a patient support and empowerment approach to treatment, while tb 
programmes use Dot. 
AIM: to evaluate changing a tb treatment model from Dot to an approach based on the 
community antiretroviral therapy (aRt) model in Cape town, south africa.
METHODS: Four studies were conducted as part of the evaluation of a new model called the 
enhanced tuberculosis adherence (eta) programme in primary health clinics. a mixed method 
approach was used. study i: seven key informants involved in the development or implementation 
of the eta, or knowledgeable of tb treatment policies in south africa, were interviewed. Data 
were analysed using thematic content analysis, and examined for their relation to the Kingdon 
framework of agenda setting to explore why the eta was developed. study ii:  six nurses and 
five adherence counsellors were interviewed, and 64 treatment supporters were included in focus 
group discussions in order to explore their experiences of the eta. Data were analysed using 
thematic content analysis and examined for their relation to the normalization process model. 
study iii: 28 patients on the eta intervention and 31 patients in comparison clinics were included 
in focus group discussions in order to explore their experiences of tb treatment. two non-adherent 
patients were interviewed. Data were analysed using thematic content analysis. study iv: using 
a time series design, TB treatment outcome data on 19 357 patients from five intervention and 
five comparison clinics were collected from the electronic TB register from 1 January 2005 to 31 
march 2008. outcomes were analysed using poisson regression. 
FINDINGS: study i: the intervention was developed due to problems in tb management, 
the availability of an alternative model in the community aRt treatment programme, political 
changes (including a focus on empowerment), and impending large-scale aRt roll-out. the 
change was facilitated by key individuals. study ii: the main issues hindering the normalization 
of the programme within clinics related to hierarchical relationships, teamwork, training needs, 
insufficient internalisation of the empowerment approach by staff, and logistical and management 
issues. study iii: intervention patients seemed to have more positive opinions of tb treatment than 
comparison clinic patients. there was some indication that eta patients were more ready to take 
control over their health, although there was little evidence of patient empowerment. study iv: 
There was a significant improvement in smear conversion rates at 2 and 3 months in intervention 
clinics relative to comparison clinics. There was no significant difference in TB cure or treatment 
success rates. 
CONCLUSION: the eta seems to be an approach that is feasible to implement in primary health 
clinics. It achieved results not significantly different from those of DOT, but was appreciated by 
patients. Further efforts are needed to empower tb patients. overall, the eta is a promising 
approach that now needs to be tested on a wider scale, and that could pave the way towards 
integrating tb treatment programmes with aRt programmes in south africa and other high-
burden settings. 
Keywords: tuberculosis, directly observed therapy, patient empowerment, adherence, south 
africa
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About this thesis
When I moved from Finland to South Africa at the age of 16, I thought tuberculosis (TB) was 
something landed gentry died from in the eighteenth century, gently coughing blood into their 
white lace handkerchiefs. i was perhaps less than well educated. i learned part of the truth a few 
years later when visiting a friend and being shouted at not to use a chipped cup, because it was the 
cup of someone who lived in the back yard – an alcoholic and a drug addict. i was told that i could 
get tb from that cup. tb was now slightly more real to me, and very disturbing. 
Possibly under the influence of too many soap operas, at the end of my school training I chose 
psychology as my future profession. When faced with the choice of clinical or research psychology, 
i thought that in a multicultural, multilingual society someone who speaks english, but barely 
understands the english culture in south africa, would not be appropriate as a clinical psychologist. 
i therefore chose to study research. psychological research is not, however, one of south africa’s 
priority research fields, and I ended up as an intern in a research organisation which doubled as 
a non-governmental organisation (ngo) and focused on injury prevention. i was introduced to 
community based research there, coincidentally working in one community that was part of this 
thesis. I was then introduced to my first South African township. 
i was later offered an opportunity to do a qualitative systematic review on adherence to tuberculosis 
treatment. though i did not know that much about tb, i wanted the opportunity to use and develop 
my qualitative skills. i was introduced to the issue of directly observed therapy, and having observed 
the disempowerment of some south african communities and having also personally experienced 
some of the negative characteristics of the south african health system; it was an issue to which i 
could relate. the review took some time, and i heard of an opportunity to do work on evaluating 
a tuberculosis treatment programme while finishing the qualitative systematic review. As I had 
wanted to continue my studies, i felt this was an opportunity to work in an interesting area, and 
this work could also form my phD. i would also have the opportunity to be supervised by my co-
author from the systematic review, incidentally it would be my first long-term contract, and I could 
possibly register at Karolinska institute. there was, therefore, no real choice. 
having completed the qualitative systematic review, i had formed a rather negative perception of 
Dot. For the duration of this work, i tried to keep these opinions explicit, and attempted to counter 
their influence on my analysis or interpretation of the results. This thesis brings together the results 
of four years’ work on evaluating the enhanced tuberculosis adherence (eta) programme. this 
thesis will contribute to the discussion on the empowerment of tb patients and on the integration 
of tb and aRt programmes through discussing the eta programme that was modelled on the 
south african community antiretroviral treatment programme.
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introduction
tuberculosis (tb) is one of the oldest and most feared diseases in the world [1]. it remains a major 
global health threat despite treatment having been available for over 50 years [2]. after the advent 
of anti-tuberculosis drugs, tb was considered virtually eradicated in high-income countries [3] 
and to be under control globally [4]. however, over a half a century later tb was declared a global 
emergency [3]. 
the need to curb the epidemic was followed by the development and global implementation by 
the World health organisation (Who) of a tb control programme – Directly observed therapy 
(short Course) (Dots) – now referred to as the internationally recommended strategy for the 
control of TB [3].  When DOTS was first implemented, in 1994, it was estimated that 1.9 million 
people had died from tb in 1990, and increasing numbers of people were dying annually [3]. 
tb was again declared an emergency in africa in 2005 [5]. in 2009, over a decade after implementing 
the Dots strategy and some years after the transition to the stop tb strategy, there were an 
estimated 9.4  million incident cases of TB, most of which were in Asia and Africa  [6]. Especially 
in sub-saharan africa, the tb epidemic has been driven by the hiv epidemic [7]. internationally 
approximately 1.6 million people in total, including 1.3 million HIV-negative people and 0.38 
million HIV-positive people, died from TB in 2008 [6]. Incidence rates of all forms of TB in some 
countries, such as South Africa, are over 900 cases per 100 000 residents [6]. 
the contribution of tb to morbidity and mortality is therefore large; tb was estimated to be the 
seventh leading cause of death and the 11th leading cause of disability worldwide in 2004 [8]. the 
global burden of tb is still considerable today, even if the global incidence of the disease has been 
decreasing slightly since 2004 [9].
The treatment and control of TB is made more difficult by the magnitude of the problem and the 
complexity of the forces driving the epidemic.  globally, tb control has been approached from a 
public health perspective, which is discussed briefly below. 
tHE PublIC HEAltH fRAMEwORk
public health is traditionally concerned with the health of populations, and aims to improve health, 
prolong life and improve quality of life [10]. programmes within this framework have taken both 
a population and an individual approach to improving the health of populations [11]. 
Although public health is used widely, the definition of public health may change between 
applications; therefore, the term may be seen as being contested [12]. one perspective on public 
health adopted a narrow biomedical definition that concentrates on ill health, whereas the other 
perspective adopted a more broad definition which includes the social and economic causes of ill 
health [13]. The main characteristics of the latter definition of public health include an emphasis 
on a collective responsibility for health and the role of the state in protecting the public’s health; 
3
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a focus on whole populations; an emphasis on prevention; concern for underlying socio-economic 
determinants of health and disease and more distal risk factors; a multi-disciplinary basis that 
includes quantitative and qualitative methods; and partnership with the populations served [14]. 
TB control could be seen as originating from the sphere of the biomedical definition of public 
health. the assumptions underlying the Dots policy (discussed in more detail later) are that 
smear-positive patients are most infectious, and treating smear-positive patients prevents the spread 
of tb [15]. the policy therefore focuses on ill health, rather than on the larger social determinants 
of health. however, it is increasingly being recognised that tb control cannot succeed without 
attention to the numerous factors that both influence the high incidence of the disease and affect 
patients’ ability to adhere to treatment. these factors include broader social and cultural issues 
[16, 17] which are key to managing TB. It has also been suggested that approaches that do not 
include these aspects should be questioned [18]. possibly due to this recognition, the stop tb 
policy has begun shifting the focus to the wider definition of public health, and has attempted to 
take into account the broader socio-economic determinants of the disease, including empowerment 
and community participation [9]. however, Dots, and therefore Dot, remains at the core of the 
new stop tb policy. 
Dots, and one of its components, directly observed therapy (Dot), could be seen as particularly 
contrasting with the wider definition of public health, since it could be seen as focusing  on 
controlling patients. In contrast, the central concept within the wider definition of public health, 
which seeks to redress inequalities and  change the determinants of health through community-
based and collective action, is power and empowerment [12]. the inclusion of empowerment within 
tb management has become more poignant since the emergence of extremely drug-resistant tb, 
which has led to considerable discussion about confinement and patient rights [19]. In addition, the 
hiv epidemic combined with the human rights focus of the hiv programmes [20] and support of 
people on antiretroviral therapy (ART), may also have influenced incorporation of empowerment 
issues into discussions about tb management. this shift within debates on the management of 
tb and the inclusion of empowerment within the stop tb policy could suggest that there is also a 
greater focus on health promotion activities in tb control.
 
health promotion is a key element of public health practice. health promotion approaches see health 
as a positive concept, not only as an absence of disease [21].  actions within the health promotion 
approach focus on individuals, but also on the social, environmental and economic conditions in 
order to alleviate their impact on public and individual health [10]. empowerment is one of the 
central characteristics of health promotion programmes [22]. health promotion therefore aims to 
increase individuals’ control over the determinants of health, and to improve their health through 
these [10]. the enhanced tuberculosis adherence programme (eta), the programme which is the 
focus of this thesis, could be seen as being part of a health promotion approach to tb treatment. 
this thesis presents parts of an evaluation of the eta programme, which is modelled on the aRt 
community support programme. the following sections will provide background to this programme 
through introducing the goals and targets of tb management efforts, the policies designed to reach 
these targets, and the challenges facing tb management. 
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 GOAls AND POlICIEs fOR MANAGEMENt Of tHE tb EPIDEMIC
Goals and targets for halting the spread of tb
the millennium Development goals (mDgs) are goals which are designed to meet the needs of 
the poorest in the world. these goals focus on, among others, ending hunger, reducing poverty and 
promoting education and gender equality [23]. MDG 6.c includes a focus on TB: it sets as a target 
halting and beginning to reverse the incidence of malaria and other major diseases [23], including 
TB. The specific TB-related indicators are incidence, prevalence and death rates associated with 
tb, and proportion of cases detected and cured under Dots [24].
The Stop TB goals have been aligned with the MDGs. They were initially launched in 2006 and 
revised in 2010 in order to take into account progress made and more recent estimates [9]. the 
stop tb targets in the revised document from 2010 [9] are outlined in table 1 below.
Table 1: Focus areas and goals of the Stop TB partnership
focus area stop tb Goals, 2011-2015 
Global burden of TB Halved by 2015 compared to levels in 1990
Incidence of active TB Reduce to less than 1 case per million population by 2050
Treatment success Successful treatment of 90% of smear-positive cases by 2015
HIV testing 100% of TB cases tested for HIV
Cotrimoxazole preventive 
therapy
Enrol 100% of HIV+ TB cases
ART Enrol 100% of HIV+ TB patients by 2010
Multidrug-resistant (MDR) TB Treat 100% of confirmed cases of MDR by 2015
Funding Mobilise 46.7 billion US dollars for the 5-year strategy, of 
which 79% is dedicated to implementation and 21% to 
research and development 
The original targets of the Stop TB programme published in 2006 were ambitious, and these were 
increased after revision for the 2011-2015 strategy. Despite these goals, recent reports indicate 
that the world is not progressing fast enough to halve tb mortality by 2015 [25], and with present 
strategies and instruments the goal of eliminating TB by 2050 will not be met [26].  In addition, 
according to the mDg report of 2010 [22], tb management only inches forward. the report 
indicates that the global incidence is falling slowly, and prevalence is falling everywhere except in 
the Commonwealth independent states (Cis) of asia1 and sub-saharan africa [23]; and mortality 
is falling everywhere except in the Cis of asia. though mortality rates are falling in sub-saharan 
africa, they are not returning to the levels of prior to 1990 because of the hiv epidemic [23]. the 
2010 mDg report therefore estimates that while the world may halve tb mortality by 2015 if 
control efforts and funding are sustained, this goal will not be attained in sub-saharan africa [23]. 
1 the Cis asia include 8 countries: armenia, azerbaijan, georgia, Kazakhstan, Kyrgyzstan, tajikistan, turkmen-
istan and uzbekistan (www.http://mdgs.un.org/unsd/mdg/host.aspx?Content=Data/Regional/cis.htm)
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the stop tb partnership, however, has more optimistic indicators, suggesting that the global 
incidence of tb has been falling slowly but steadily since 2004, and they suggest that it is possible 
to reduce tb to less than 1 case per million residents - if there are radical transformations in 
diagnosis, treatment and prevention of tb [9]. however, in terms of progress in south africa, a 
recent analysis suggests that the only goal that might be attained is detection and cure of tb cases 
under Dots – the rest of the indicators are unlikely to be attained according to present trends [27]. 
Considerable investments are therefore likely to have to be made in diagnosis, prevention and 
treatment of tb globally, but in particular in sub-saharan africa.
global progress towards the stop tb goals has also been relatively slow. While 100% of tb 
patients are to be tested for HIV in 2015, only 26% were tested in 2009, and only 1.9 million TB 
patients globally knew their HIV status [6]. However, estimates that 80% of HIV- positive patients 
were enrolled on cotrimoxazole and 40% on ART in 2008 [6], does represent some progress 
in managing the global tb epidemic. however, particularly poor indicators were given for the 
diagnosis and treatment of mDR tb. Despite these mixed results, mobilization of funding seemed 
to have succeeded, although much was invested in mDR tb treatment [24].
the mDgs and the stop tb partnership goals are important in working towards containing tb, 
since they can increase political attention on the tb epidemic. however, tb treatment programmes 
continue to face challenges - such as the growing problem of drug resistance - which is likely 
to be the result of  poor adherence to treatment and wider health-system related problems [28]. 
in addition to political commitment, then, new innovations and general improvements in health 
systems [29, 30] are needed to reach the goals. the section below reviews the policies designed 
for curbing the tb epidemic. 
Policies for management of tb
the Dots policy, a key policy in tb management, has been highly successful in terms of 
national alignment: in 2008, 202 countries reported implementing the strategy [26]. The approach 
has strengthened tb control at many levels, including increasing governments’ attention to tb 
control; channelling new resources to tb treatment programmes; strengthening drug supplies and 
information systems; health education; continuity of care; and good follow-up and information 
systems [31]. there is also some evidence that the strategy as a whole has improved treatment 
success rates, although it is unclear which component of the strategy is responsible for this increase 
[32]. Despite these successes it has not yet halted the global spread of tb. 
The DOTS policy has five key elements [33]:
1. political commitment to tb control;
2. Case detection by sputum smear microscopy;
3. Standardized treatment regimen of 6 to 8 months of DOT;
4. Regular, uninterrupted supply of tb medications; and
5. a standardized recording and reporting system. 
This policy evolved into the STOP TB policy in 2006, in response to indications that the DOTS 
strategy alone was not sufficient to achieve the 2015 TB-related MDGs [34]. However, the Stop 
tb policy re-emphasises the importance and central position of Dots [28]. 
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the general aim of the stop tb strategy is to dramatically reduce the global burden of tb [35] 
which, it suggests, can be achieved through the following six initiatives [36]:
1. pursue high-quality Dots expansion and enhancement; 
2. address tb/hiv, mDR tb, and the needs of poor and vulnerable populations;
3. Contribute to health system strengthening based on primary health care; 
4. engage all care providers;
5. empower people with tb, and communities through partnership; and 
6. Enable and promote research.
 
as can be seen from the above, the stop tb policy has expanded its focus from the Dots policy 
by including the wider drivers of the tb epidemic. however, the stop tb policy retains Dots 
expansion as one of its goals. Dots includes a focus on directly observed treatment (Dot), a 
method that is contested widely. the following section highlights some of the key debates involving 
Dot. 
Debates around DOT
For patients, and possibly also for health care providers providing treatment, the key part of the 
Dots and stop tb policies is Dot. Dot implies that treatment is taken by a patient under 
supervision by another person, often a professional or lay health provider [36]. Although DOTS 
is a global policy and the intention is that it facilitates a uniform approach across settings, the 
implementation of Dot varies considerably across contexts [37], as does its quality [28]. both 
providers and places of treatment provision may differ [37], which makes it difficult to assess the 
impact that Dot has on treatment outcomes.  in south africa, Dot is usually provided at a clinic 
by a professional nurse; at a lay or community health worker’s2 [38] home in the community; or at 
the patient’s workplace by their supervisor [39].
although the Dots strategy in general has been found to be useful in managing the tb epidemic, 
the debates and research surrounding the Dot component (e.g. noyes & popay (2007) [40] and 
Volmink & Garner (2007) [40, 41]) have resulted in a modification of some of its aspects. For 
example, the observer responsible for a patient taking their treatment has changed from having 
to be a health professional to the possibility of a lay health worker observer, and more recently 
to a family member [42]. Despite these modifications, observation has remained as a key part 
of the Dots strategy, at least in the south african setting. this is despite a systematic review 
suggesting that Dot may be no more effective than self-administration of treatment by patients 
[41]. Although it is difficult to make firm conclusions about the effectiveness of DOT, given the 
differences in the ways that Dot is implemented in different settings [41], there remains strong 
evidence that Dot may not be necessary to contain the tb epidemic. 
Despite this evidence suggesting that Dot may not be a useful approach, it is still part of Dots 
and the stop tb strategy [9], although now presented together with patient support. authors have 
noted, however, that there remains little guidance on how this component of patient support is to be 
2 A lay health worker can be defined as any health worker delivering health care; trained in the context 
of the intervention; and having no formal health professional or paraprofessional tertiary certificate or 
degree [38]
Introduction
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implemented in practice [43]. using Dot to provide treatment for patients is not without problems. 
the nature of the intervention seems to reinforce imbalances of power and capacity between the 
public health profession and the infected person [44], since the person with tb is required to have 
each dose of treatment observed and needs to comply with appointments, on terms which are 
often not negotiable and are decided by the health care system. in addition, requiring patients to 
be observed by another person often requires that patients travel to a clinic or another site in the 
community, which results in transport costs and lost opportunities to earn a living while travelling 
and waiting for treatment [16]. Partly due to these issues, DOT has been criticized as being negative 
and dehumanising, and as one of reasons that patients disengage from services [40]. 
there have been more recent attempts at making Dot easier for patients. having family members 
observing treatment has been suggested as a viable alternative to having the patient receive their 
treatment at a clinic or in the community [42]. however, this has been criticised for being a risky, 
feel-good strategy [45]. the authors, who support observation by health care workers, also assert 
that family members might not understand treatment, and that in places where there are existing 
power differentials within the home, supervision by another family member might not be possible. 
however, treatment supervised by a health care worker is not as cost-effective as other options 
[46], and family member-observed treatment for TB has been found to be effective in at least 
certain settings [42] . in addition, tb interventions could be expected to include information for 
patients and possibly also for their families on treatment requirements and the treatment course. 
little is also known of the processes that take place while a family member is asked to observe a 
tb patient’s treatment. asking a family member to observe treatment may result in an imbalance 
of power in the home, regardless of whether the family member required to observe treatment is 
below the patient in the family hierarchy or not. it is also possible that instead of directly observing 
the patient taking their treatment, family members remind and motivate the patient to take their 
tablets. Reframing ‘family- observed’ as ‘family-supported’ treatment is therefore not difficult. 
Dot then becomes a matter of discourse, and any effects of family member-observed treatment 
may not be due to the act of observing treatment; rather, the treatment could be self-administered 
with family member support.
Whatever mode of treatment is used, adherence to treatment is a key issue, and one of the major 
challenges to managing tb. adherence and other challenges to managing tb are discussed below. 
CHAllENGEs tO MANAGING tb 
as indicated earlier, the management of tb faces a number of problems. although a global, 
structured plan to manage tb epidemics has been constructed, tb treatment programmes need 
to be tailored to local settings, and implementers need to pay attention to key epidemiological 
characteristics and resources available [47, 48], as well as to local values, beliefs and preferences 
regarding taking treatment. active tb is not only the result of infection with the tb bacillus - the 
socio-economic characteristics of the setting influence whether a patient develops active TB or 
not [1]. tb epidemics have complex relationships to socioeconomic factors [18], and the disease 
continues to affect the poor and marginalised [18]. this, combined with challenges within health 
systems [25], such as poor access to treatment [26], make managing TB a complex and challenging 
task. 
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Although TB drugs have been available for decades [49] and most patients can be cured [36], it has 
been suggested that there is there are still a number of challenges to overcome in order to eradicate 
the disease [26]. Some of these include MDR TB and extremely drug-resistant (XDR) TB, lack of 
drug and vaccine development, patient adherence to tb treatment, and tb and hiv co-infection. 
in addition, there are a number of important health systems challenges; these are discussed later 
with specific reference to the South African context. 
the emergence of mDR and XDR tb as a consequence of weak health systems, inadequate 
management and erratic treatment [28], possibly including irrational use of antibiotics [50, 51] or 
patient non-adherence [52], has meant that treatment takes longer and costs more, and mortality 
rates are increased [53]. all of this places strain on already burdened health care systems. While 
mDR tb has been recognised for over two decades [54],  XDR tb arose more recently in south 
Africa [55], and has been since identified in many countries globally [56]. Reports have also 
surfaced of tb strains that are resistant to all available antibiotics [57], raising the possibility of 
incurable tb – an alarming prospect given the existing problems in treating a curable form of tb. 
While drug-resistant strains can be spread from person to person, they may also often develop 
in the contexts of HIV and of inappropriate treatment or poor adherence [56]. Drug resistance 
therefore makes adherence to treatment a priority. 
the increasing problem of drug resistance also means new drugs to contain the epidemic have 
to be developed urgently [49]. there has been a lack of meaningful drug development over the 
past five decades [19]. There is also a need for an effective and affordable TB vaccine [58], the 
lack of which places increased emphasis on the need for effective treatment programmes. new 
drugs and vaccines could contribute towards curbing the disease. the unavailability of new drugs 
and vaccines necessitates effectively using those tools and resources available to treat tb. this 
includes exploring new ways of delivering care, in order to improve adherence to treatment and 
therefore improve treatment outcomes. 
Adherence to tb treatment
adherence is a term that arose in response to the negative connotations associated with ‘compliance’ 
[17]. Compliance has been seen as incorporating a hierarchy and power differences between patients 
and medical professionals  [59]. adherence could be seen as incorporating the self-management 
of treatment and the importance of cooperation between the provider and the patient [17], and 
is a more neutral term than compliance. adherence to long-term therapies is complicated, and 
notoriously difficult to achieve [60]. In TB treatment programmes adherence is a central issue, 
since non-adherence can result in prolonged infectiousness, drug resistance, relapse, or death [41]. 
non-adherence can therefore have consequences for the individual, their family and the wider 
community, and can set back tb control efforts even where medication is widely available. non-
adherence will also result in increased health service costs, since retreatment and drug-resistant 
TB treatment costs more [61]. Reducing non-adherence to TB treatment is seen as key to reducing 
mortality and improving treatment success [62] - but it has long been known that up to half of all 
patients with TB do not complete their treatment [63].
the problem of non-adherence to tb treatment has been investigated for decades. the debate on 
compliance has shifted from blaming certain ethnic groups for non-compliance, to victim blaming 
[64]. More recently it has been suggested that attributing adherence to personal motivations may 
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not be helpful [16]. Adherence to TB treatment is a complex issue [60], and closely connected 
with larger societal and historical forces [65]. As could be deduced from the concentration of the 
epidemic in Asia and Africa, TB tends to affect the most vulnerable populations [66], and the most 
vulnerable and disadvantaged persons within those [67]. treatment adherence is therefore closely 
related to social inequalities [65] and their impacts on health and health care [64]. 
A recent systematic review of qualitative studies indicated some of the factors that may influence 
tb treatment completion. it highlighted structural factors, patient-related factors, the social context 
and health service-related factors [16]. The results of the systematic review are expanded on below. 
In terms of structural factors, poverty and the financial impact of TB treatment have been found 
to be a major influence on adherence. Patients may hide their disease from employers for fear of 
dismissal, which may result in non-adherence. They may also have difficulty in obtaining sick 
leave to attend treatment. in addition, work may often take priority over taking treatment, since 
patients have a responsibility to provide for their families; attending treatment could conflict with 
their work seeking or work attendance. hidden costs of treatment, such as costs for X-rays in some 
settings or travel costs, could also impact on adherence, especially in impoverished settings. gender 
discrimination is another structural factor that may influence treatment adherence, especially in 
some asian settings, where females’ tb status is sometimes hidden since tb-related stigma may 
result in divorce or reduced prospects of marriage. 
patient-related factors include their motivation for staying on treatment, and the psychological 
and physiological impacts of the treatment. the knowledge of, attitudes towards and beliefs about 
tb and its treatment may affect adherence – for example, a patient who believes in a different 
aetiology of the disease, does not understand treatment requirements, and does not trust the health 
care system, may be non-adherent. patients’ interpretations of illness and wellness may also affect 
adherence in that they may consider themselves cured when they no longer have tb symptoms.
the social context, then, includes the response of the family and community to tb and the patient. 
patients encounter stigma in many settings, which may result in hiding the diagnosis and being non-
adherent. social support seems to be a key feature in promoting adherence. lack of this support 
may contribute to a patient stopping their treatment [16]. 
All of these factors are interrelated, and also interact with health service-related factors [16]. 
Factors related to the health service include the relationship between the provider and the patient: 
a negative relationship and being scolded for non-adherence may result in the patient not returning 
to the health centre. access to health services may also be a barrier to tb treatment adherence, 
since opening times of facilities may be inconvenient, or distances to travel can be far. health 
services being inflexible and not including a choice for patients could also result in non-adherence 
[16].  
Later studies have emphasised the role of unemployment and alcohol abuse [62] as factors 
influencing treatment non-adherence. Without question, however, all aspects of a TB patient’s 
day-to-day life are affected by tb [43], and support is needed to increase adherence to treatment 
taking. patients could also be seen as choosing to adhere [31], in that they have to make difficult 
choices between different priorities, of which tb treatment is only one. based on this, health 
services would then need to make additional efforts in order to ensure that adhering to treatment 
is easier for patients. 
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these issues related to adherence become especially complex when the patient is also hiv positive. 
For example, a study conducted in Cape town suggests that patients may become non-adherent 
to their antiretrovirals (ARVs) when they have completed their TB treatment [68]. This indicates 
further that hiv-tb co-infection is a major challenge to tb control, especially in settings where 
hiv is endemic. this issue is discussed in more detail below. 
tb and HIV co-infection
Globally, HIV-associated TB remains a major challenge [69], and it is possible that without HIV 
infection, global incidence of and mortality due to tb could be falling [30]. approximately 11 
million people are affected by this co-morbidity, and nearly 200 000 died from it in 2005 [70]. tb 
is the most significant cause of morbidity and mortality for HIV-infected people [71]. In comparing 
the 2008 and 2009 WHO reports, Hanekom et al. [69] noted an apparent two-fold increase in the 
estimated disease burden of hiv-associated tb. although this increase is, according to the authors, 
mainly due to the increased availability of data, hiv-associated tb is a strain on health systems 
globally. in hiv endemic countries, the treatment of tb only has a limited impact on reducing tb 
incidence [28].  
Despite the interactions between the two epidemics, hiv and tb programmes have traditionally 
been organized in separate, vertical programmes, with a duplication of resources and little 
communication between them [30, 72]. almost all countries have a tb control programme, but 
hiv programmes are still in their infancy in some settings [30], and it has been suggested that 
the failure to respond in time to the hiv and tb epidemic has resulted in missed opportunities 
[73]. the global response to the challenge of co-infection has been described as “timid, slow and 
uncoordinated” (p. 1906) [74]. The reasons for a slow response to this epidemic include a lack of 
human, financial and institutional resources, and insufficient political will [30]. The co-epidemic is 
also worst in sub-Saharan Africa [69], where there are even fewer of these resources. 
enhanced coordination among hiv, tb and other major disease control efforts is seen as both 
logical and practical [28]. Collaboration has been made more urgent by the scale-up of aRt 
together with the increase in mDR and XDR tb [74]. in addition, the roll-out of aRt may take 
up some of the human resources previously allocated to tb and other services [75].  it is also 
suggested that the hiv-associated tb epidemic will not be halted without more imaginative use of 
available and potential strategies [74], which could include increased integration of treatment for 
the two diseases. 
better integration of tb and hiv treatment programmes has been recognized as key to improving 
treatment outcomes and quality of life of people living with both conditions [72, 76, 77]. The 
influences on the outcomes of the two diseases are the same - large-scale social forces, which are 
rooted in historical and economic processes [78]. hiv, like tb, has also affected the disadvantaged 
the most, as can be seen by the diseases’ prominence in low- to middle-income countries. because 
of the similarities of the populations affected by these diseases and the high rate of co-infection, 
there seems to be no logical barrier to attempting to have a more coordinated response to the two 
diseases, even if there are differences in treatment and disease progression.  
Coordination of hiv and tb programmes could be achieved by integrating treatment at the community 
level, at the organisational level or at the policy level. at the international policy level integration 
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has been seen as an important goal [79], and national guidelines and programmes emphasize 
the importance of integrating tb and hiv programmes (e.g. [80]). however, the challenge is to 
implement this approach at both the organisational level and the community level [81]. 
to date, published examples of integrated treatment at community level are few, although there 
are some examples from Malawi and South Africa [76]. These programmes are integrated to 
different degrees. one of the south african examples is a prospective operational study in one 
sub-district using home-based, modified DOT [82]. A total of 119 patients had their daily doses of 
tb and aRv medication observed at their homes, either by a lay worker or a family member, after 
having completed an HIV/AIDS training curriculum [82].  After a median of 67 days into their 
tb treatment, patients were given hiv medication, the taking of which was observed once a day 
by their Dot supporter or family member. patients on this programme achieved high adherence 
levels for their tb and hiv medication, with 83% of patients having an undetectable viral load 
at 6 months, and 84% being successfully treated for TB. However, this study included only 66% 
of all patients eligible, with the main reasons for exclusion being non-completion of a treatment 
literacy programme and unwillingness to disclose their status to the community. in addition, 
these patients were observed while taking their tb medication, and self-administered their hiv 
treatment after completing their tb medication, highlighting the contrasting approaches used in 
these two treatment programmes. 
in addition to the challenges and the few examples of practical integration of the two programmes, 
particularly at scale, the differences in the history and culture of tb and hiv treatment, added 
to territorial protectiveness within vertical programmes, have slowed the development and 
implementation of policies in this area  [30]. in most settings tb and hiv continue to be treated 
using contrasting approaches. 
treating tb and HIV/AIDs with contrasting approaches 
both tb and aRt programmes have the same goal – to keep patients taking their treatment as 
prescribed for as long as possible or, in the case of TB, for 6 months. Both are chronic infectious 
diseases that affect mainly the most disadvantaged populations, both are public health priorities, 
and both have complex drug regimens [60]. Despite these similarities and the fact that many TB 
patients are infected with HIV, the approaches to treatment could be said to conflict, with ART 
focusing more on empowerment [83] and tb focusing more on control and having an authoritarian 
approach towards patients [64]. Some of the reasons for the conflicting approaches may arise from 
the history of these two diseases, including patient involvement in care. the involvement in care 
of hiv-positive patients and the ways in which people’s identities are shaped by living with hiv/
AIDS are large areas of research, which will be touched on only briefly below. 
aiDs has had a strong human rights movement, which has informed public policy [83]. hiv-
positive people in high-income countries started to participate in aiDs-related policy making in 
the 1980s, and have made considerable contributions to many areas related to hiv and health, such 
as policies and law, research on hiv, and treatment access [84]. aRt is also viewed by patients 
more as a set of rights and responsibilities  rather than only treatment for a disease [85]. this 
movement has also been strong in south africa, where community participation, involvement and 
activism in issues related to HIV have been considerable [86]. In South Africa one of the reasons 
for this activism has been the need for better access to treatment. in many settings, therefore, 
hiv-positive people have become “expert patients” - patients who are more closely involved with 
health services [87]. 
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in contrast with the strong involvement of hiv patients in many aspects of treatment policy 
making, tb patients have been much less involved in the public domain. tb patients have not 
become activists despite calls for a human rights-based approach for tb treatment, especially from 
academic circles, for some time [44]. more recently, international health and human rights experts 
called for a human rights approach to health care in south africa [20], and among other things 
demanded a human rights approach to tb treatment. empowerment and community participation 
were also included in the Stop TB strategy of 2006 [34]. Despite these efforts, TB patients to date 
have generally not become activists for their illness, and little has changed in the way tb is treated 
in practice. 
the contrasting approaches used in treating tb and hiv have also informed the way in which 
treatment programmes are organized. tb is treated through Dot, which can be very resource-
intensive [46], since a patient needs to see a health professional or a lay health worker every day. In 
south africa aRt for hiv-positive patients is usually provided through self-supervised, supported, 
community-based treatment [88], where patients are required to see a professional nurse or doctor 
less often than in tb treatment. patients on aRt are also monitored less intensively than tb 
patients, but the aRv model is based on intensive treatment preparation, empowering patients to 
undertake self-administered therapy, and community-based lay treatment support [88]. in contrast, 
tb patients need to start their treatment immediately and do not have a treatment preparation 
programme, and the information they receive has traditionally focused on biomedical aspects of 
their disease rather than the psychosocial aspects [89]. 
studies indicate that patients who self-administer their aRt can achieve high adherence rates 
at 6 months [68, 90], and a high proportion of these are retained in care after 6 months [91], at 
least in selected settings in sub-saharan africa [92]. although the adherence rates of aRt and tb 
programmes are difficult to compare due to different methods of measuring adherence and treatment 
success, tb programmes do not seem to be able to achieve the same high rates of patient retention 
on treatment. tb treatment success rates remain relatively low, and below the international target 
of 85% [6]. The question remains, however, whether the high adherence rates achieved by the ART 
programmes are sustained when aRv medications become more widely available and enrolment 
into these programmes is less selective [52]. some results from Kenya suggest that these high 
adherence rates may not be sustained in high-risk, highly mobile, resource-limited settings [93]. 
Despite the challenges in measuring success in these two programmes, and the conflicting approaches 
taken to treatment, the similarities between hiv and tb and the rates of co-infection suggest that 
an integrated approach is needed. as the approaches of the current treatment programmes contrast, 
at least at the patient level, changes would have to be made to programmes in order to integrate 
treatment. the alternatives are a new treatment delivery programme for both; Dot for aRt and 
tb [94]; or self-administered treatment for aRt and tb. there is, however, little evidence of the 
effectiveness of Dot for tb treatment [41], or for aRt [95]. the good outcomes achieved by 
hiv programmes that provide community-based treatment through an empowerment approach 
[90], although in limited settings, suggest that the approach should be evaluated in tb care. given 
the paternalistic approach of Dot [40], self- administration based on more empowerment-focused 
approaches may be the preferred option for patients. 
the following section gives a brief overview empowerment, the central issue in this thesis.
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PAtIENt-CENtEREDNEss AND EMPOwERMENt
in 1978 the alma ata declaration recognised that people have a right to participate, both individually 
and collectively, in their own health care [96]. The Ottawa Charter took this further in 1986, stating 
that power should be shared between health services and communities [21]. it is increasingly also 
recognized that inclusion, agency and control are important for people’s health and well-being [29]. 
authors have also suggested that patients are experts on their own bodies, and this knowledge is 
essential for successful treatment [97]. this move towards sharing power and recognising patient 
expertise suggests that approaches to care that incorporate the concepts of patient-centeredness 
and empowerment could be beneficial for TB patients and eventually for treatment outcomes. 
patient-centeredness is not synonymous with empowerment, but the concepts are complementary. 
patient-centred care refers to the context of clinical health care settings and the relationship between 
caregiver and patient [97], while patient empowerment focuses on empowering individuals and 
sometimes groups of individuals, and is broader and more challenging for caregivers and healthcare 
organizations. patient-centred care is not limited to communication, and often also focuses on 
other aspects of care such as accessibility of services [98].
empowerment, on the other hand, can be seen as a process by which people can gain mastery over 
their own lives; it can lead either to a sense of control or practical power to effect change [99]. it 
could be seen as the process of “enabling people to choose to take control over and make decisions 
about their lives” (p. 309) [100]. The benefit of empowerment approaches is that they focus on 
capabilities and the environmental influences of social problems, rather than victim blaming and 
risk factors [101], and posit patients as responsible for their choices and the consequences of their 
choices [102]. 
there is a need for patient-centred services in tb care [40, 103], and a need for a shift from 
controlling patients to supporting them [17, 66]. However, patient-centeredness and empowerment 
are not new concepts within tb care [104]. there have been a number of attempts to introduce 
a patient-centred approach in tb care [105-107], and interventions to increase the patient-
centeredness of care delivered by physicians have had positive results on patient satisfaction and 
on how care is delivered [108]. in tb care one of the challenges to providing patient-centred care 
has been identified as the rigid, task-orientated implementation of DOTS by nurses within TB 
clinics [109, 110]. 
some authors have also criticised these approaches, stating that it has become part of the rhetoric 
of health professionals but has not translated into action [111]. however, the development and 
implementation of empowerment-focused programmes is difficult, since one cannot ‘give’ 
empowerment to someone - people must themselves want it and gain it [12]. there are also too 
few published examples of how patient-centred or empowerment-focused programmes are to be 
implemented within the context of tb [104], and the stop tb policy gives little guidance on 
its implementation [43]. Developing programmes with an empowerment approach also requires 
community or target group participation from the beginning - from defining the problem to 
finding the solution and defining the ways in which the problem is addressed [12]. This method of 
developing programmes - especially those which are to deliver a public health intervention - may 
require considerable time and effort. time is not always available, especially given the urgency 
of treating an infectious disease such as tb. tb treatment, then, may be an area in which it is 
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particularly challenging to develop an empowering programme, not least because tb treatment is 
traditionally focused on the control of patients [64]. 
some of the ways in which communities can be part of tb treatment programmes is through 
employing community health workers or recruiting key members of communities to provide input 
or feedback to health care systems. For some time researchers and policy makers have called for 
the involvement of civil society, community representatives and patients as part of tb control [30, 
112]. Within the empowerment approach communities can have a central role in the fight against 
tb [111]. existing programmes that have included community participation in tb treatment have 
focused on, among others, increasing awareness of the disease; case detection and referral for 
diagnosis; increasing access to drugs; addressing stigma; and supporting and motivating patients 
[113]. the results of these studies suggest that community involvement in tb treatment may be 
beneficial.
the programme focused on in this thesis has been posited as taking an empowerment approach to 
treatment, by facilitating individual patients to take control over their treatment course and their 
health.
tHE PROblEM
Despite the synergies between the hiv and tb epidemics in south africa, the diseases continue 
to use contrasting approaches to treatment delivery and support. tb treatment is managed using 
Dot, while aRt programmes are based on supported self- administration and come from the 
sphere of empowerment. there is an urgent need to integrate these two treatment programmes, 
which could be done through using the community aRt programme for tb. this approach would 
respond to policy makers’ and researchers’ calls for including an empowerment approach in tb 
treatment programmes, and would be aligned with the stop tb policy. 
however, to date there is little published evidence of the effectiveness of empowerment-based 
tb programmes [104], and little guidance on how empowerment-focused programmes should be 
implemented in practice [43]. 
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Aim And reseArch questions
the aim of this thesis is to examine changing a tb treatment model from Dot to an approach 
based on the community aRt model.
General research questions:
1. Why was the eta developed? (study i)
2. What were the key issues that influenced the implementation of the ETA from staff 
perspective? (study ii)
3. how did the eta affect patients’ experiences of tb treatment? (study iii)
4. What impact did the eta have on tb treatment outcomes? (study iv)
Specific aims of articles I-IV:
i. to examine the development of a new tb treatment support programme modelled on the 
community aRt programme
ii. to explore staff perceptions of implementing the eta
iii. to explore patient experiences of a tb treatment programme modelled on the community 
aRt programme
iv. to determine the impact of the eta compared to Dot in Cape town, south africa
the structure of this thesis is guided by the research questions. 
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methods
OVERVIEw Of  stuDy DEsIGN
table 2 presents an overview of the thesis and the studies within it. 
Table 2: Overview of studies in the thesis
study Research question
Design and 
method
subjects and 
sample setting
Data 
collection
I Why was the 
ETA developed?
Qualitative 
explorative 
study
5 managers and 
developers of the 
new intervention 
and 2 academics 
involved with TB 
policy
Cape Town Semi-structured 
interviews with 
all participants
II What were the 
key issues that 
influenced the 
implementation 
of the ETA 
from staff 
perspective?
Qualitative 
exploratory 
study
5 adherence 
counsellors; 6 
TB nurses and  
64 treatment 
supporters
5 clinics 
providing new 
intervention 
within City of 
Cape Town 
health district
Semi-structured 
interviews with 
adherence 
counsellors 
and nurses. 
Focus group 
discussions 
(FGDs) with 
treatment 
supporters 
III How did the 
ETA affect 
patients’ 
experiences of 
TB treatment?
Qualitative 
exploratory 
study 
61 TB patients: 28 
intervention, 31 
comparison, two 
recalled patients
One clinic 
providing 
usual care to 
TB patients, 
two clinics 
providing 
the new 
intervention
FGDs with 
adherent 
patients; semi-
structured 
interviews with 
non-adherent 
patients
IV What impact did 
the ETA have 
on TB treatment 
outcomes? 
Time series 
design with 
comparisons
19 357 TB 
patients (over 
18 years of 
age) registered 
between January 
2005 and end 
March 2008
10 primary 
health care 
clinics within 
the City of 
Cape Town 
health district
Data collected 
from routine TB 
register
the thesis combines the use of qualitative and quantitative methods, which complement each 
other: quantitative methods can determine the effects of the programme, while qualitative methods 
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can highlight the processes and mechanisms that result in these effects and produce in-depth 
knowledge of the phenomenon [114]. the qualitative studies were done from a participatory 
evaluation perspective [115], in that the health services had an opportunity to contribute to 
research questions and comment on findings. 
using Kingdon’s [114] model of agenda setting, study i aimed to examine the reasons behind 
the decision to pilot a new programme, given the history and tenacity of the Dot approach. 
study ii examines the implementation of the programme according to staff, and presents results 
contextualised within the normalisation process model [116] (please see the later and articles 
i and ii for a more detailed description of these theoretical models). study iii examined the 
qualitative effects of the programme on patients’ experiences of tb treatment, based on FgDs 
at intervention and comparison clinics, and interviews with 2 patients who had been recalled to 
clinic treatment after having been non-adherent while on the eta model. 
using a time series design, study iv compared the tb treatment outcomes of clinics implementing 
the eta with clinics implementing Dot to establish the outcomes of the eta [117]. 
stuDy sEttING
south Africa  
south africa is a middle-income country on the southern most tip of africa, populated by 
approximately 50 million people [118]. south africa is divided into nine provinces and 52 health 
districts  [119]. the country is strongly affected by hiv – the prevalence of hiv was estimated 
at 29,4% in women attending public sector antenatal clinics in 2009 [120]. the overall hiv 
prevalence in the country was estimated at 16.9% in 2008, and approximately 5,6 million South 
africans are living with hiv [121]. the hiv epidemic in south africa is embedded in the social 
inequality coming from a history of oppression and exploitation [122], and is one of the major 
contributors to problems in the health care system. Key demographic data on south africa are 
presented in table 3. 
Table 3: South Africa’s key indicators
Population 49,99 million (estimate 2010)
Languages [123] 11 official languages, with the largest language groups being IsiZulu and IsiXhosa 
Population below poverty line ($2 per day, 
2000-2007) [124] 42,9%
Unemployment (April-June 2010) [125] 25,3%
Life expectancy at birth [118] 53,3 (male), 55,2 (female)
Literacy rate in those aged 15 and above 
(1999-2007) [124] 88,0%
Sex [118] 49% female, 51% male
Infant mortality per 1000 live births [118] 46,9
Fertility rate (children per woman in 2010) 
[118] 2,38 
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South Africa is also one of the most unequal countries in the world. The Gini coefficient, which 
measures income inequality within populations, was 0.72 in 2006 [126], which is extremely high. 
statistics south africa also reported in 2008 that the richest 10% of the country were earning more 
than 50% of household income in the country, while the poorest 40% received only 7% of the total 
household income [126].
Health care systems in south Africa
south africa utilises the district health care system to organize and provide treatment, which 
means that one health authority is responsible for primary health care and makes decisions on the 
health care for a particular district [127]. in theory, the district health system allows communities 
the opportunity to contribute to health care decisions for improved access for all and for the 
decentralization of care [127]. however, it has been suggested that the problems within south 
africa’s health care system are substantial and generally underestimated [128]. 
the proportion of the global burden of disease borne by south africa is disproportionately high 
[50], and despite global support, leadership has faltered at national level [19, 50]. one of the 
indications of the problems within the south african health care system is the emergence of XDR 
tb in south african communities [55].
there are also early indications that south africa will not reach the mDgs in many areas, including 
reducing the prevalence of underweight children, reducing the under-five and infant mortality rate, 
increasing life expectancy and decreasing maternal mortality [27]. however, some goals - such 
as improving drinking water, sanitation facilities and malaria incidence and deaths, antenatal care 
coverage and a reduction of hiv prevalence - are likely to be reached [27]. 
in addition to a high disease burden, which results in challenges to service delivery, south africa is 
also one of the countries affected by the human resources for health crisis [129], and has experienced 
a ‘brain drain’ of health personnel, both to overseas [130] and within the country into the better 
managed and funded aRv programmes [75], and into the better-paid private sector. 
the combination of high burden of disease and limited resources when compared with high-income 
countries has necessitated searching for different approaches to health care services. the Who has 
recommended task shifting as one of the approaches that could rapidly increase access to hiv and 
other health care services [131]. task shifting means that another, lower, cadre takes on some of 
the tasks of a higher cadre of health worker [132], for example lay health workers taking on some 
of the tasks of nurses.  
task shifting has been used as one way to supplement the human resource supply in south africa, 
and tb treatment programmes in south africa have depended on lay health workers for years. 
global research indicates that having lay health workers supervise tb treatment taking does 
not have negative impacts on treatment outcomes [38, 41]. Other findings of the benefits of task 
shifting include increasing access, and there is some weak evidence that it does not harm quality of 
care [133]. however, there is a need for ongoing training and supervision, and tension between lay 
health workers and nurses is possible [133]. therefore, while perhaps more cost-effective, having 
lay health workers taking on some of nurses’ responsibilities remains challenging.
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tb in south Africa
south africa has the third highest burden of tb in the world. the incidence rate of all forms of 
tb in south africa was estimated at approximately 971 per 100 000 residents in 2009 [134]. 
although the hiv epidemic in the country seems to be stabilizing [121], approximately 58% of 
south african tb patients are estimated to be co-infected with hiv [134]. the tb epidemic is 
interacting with  the hiv epidemic [120], and this, combined with growing drug resistance, means 
that south africa faces one of the worst tb epidemics in the world [128]. the toll of tb on hiv-
positive people in south africa can be illustrated by a small-scale post-mortem study conducted 
on 240 cases between 20 and 40 years of age in KwaZulu-natal in south africa. patients were 
selected if they had died in inpatient treatment at the medical or surgical ward of the hospital, were 
between 20 and 40 years of age, and consent was given by a family member for the study. patients 
who died from trauma or obstetric complications were excluded. Of the total 240 cases, 226 were 
hiv-positive; half of the patients were being treated for tb at the time of their death, while of the 
other half not on treatment, 42% were culture-positive for tb [135]. 
tb programmes in south africa follow the approach recommended in the international Dots policy. 
As most TB patients take treatment for 6 months, this is placing strain on an already overburdened 
public health system. treatment is observed at primary health care clinics [110], by lay health 
workers in the community, or by a work supervisor at the patient’s workplace [33]. however,  the 
clinics at which treatment is provided are often overcrowded and have scarce resources [136]. 
in addition, the health care professionals responsible for running the clinics and providing tb 
treatment have been described as overworked and stressed [136]. Despite implementing DOTS, 
national TB treatment success rates were 76% in 2008 [134]. While this represents an increase in 
treatment outcomes over time, it does not reach the internationally recommended target of 85% 
[6]. 
Specific setting for this study
the study took place in the Cape town metropole health district in the Western Cape province of 
south africa (see Figure 1), which could be considered relatively well resourced when compared 
with the rest of south africa. 
Cape town has approximately 3,4 million inhabitants [137] and eight health sub-districts [138]. 
as in south africa in general, the burden of hiv and tb in Cape town is high: antenatal surveys 
suggested an HIV prevalence of 16.1% in 2008 [120], and the incidence of smear-positive TB in 
the district was approximately the national average of 283.4 cases per 100 000 residents in 2007 
[139]. In 2006 77.3% of smear-positive TB cases in Cape Town were cured [140], which is higher 
than in most settings in South Africa, but remains lower than international targets. HIV was first 
and TB was third in the top causes of death in Cape Town in 2006 [141].
The five clinics in which the programme was implemented are located within three of the eight 
health sub-districts within the City of Cape town. they are located on the outskirts of Cape town, 
in areas populated by mainly Xhosa-speaking africans. the clinics involved in the study all had 
high tb caseloads (500-1000 patients per year), with an average treatment success rate of 78%, 
and similar HIV incidence, where approximately 68% to 73% of TB patients tested in 2007 had a 
positive hiv test result [142]. 
 
the next section describes the programme being focused on in this thesis.
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Figure 1: Map of South Africa with an enlargement of Cape Town health sub-districts
tHE EtA PROGRAMME
background 
City health, Cape town developed a new programme to increase adherence to tb treatment 
in collaboration with provincial health, Western Cape, and tb/hiv Care (a non-governmental 
organization (ngo) involved in the support of people on tb and hiv treatment). they began 
developing the programme in 2005. the programme is modelled on the aRt programme [88]. 
table 4 provides a description of differences between the usual Dot approach and the new 
programme. The programme is in line with the key elements of the WHO 2006-2015 Stop TB 
strategy [34], one element of which includes increased participation in treatment and monitoring 
by communities affected by the tb epidemic [143].  
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Table 4: Differences between the DOT and ETA approaches to treatment delivery and 
support
DOt EtA
Training: Standard nurse training for 
nurses; 5-day training for lay DOT 
supporters
Training: Additional 1 day induction to the ETA for nurses; 
additional 3-day induction to the programme for DOT 
supporters (now called treatment supporters); adherence 
counsellor training for ex-DOT supporters, including five 
days of programme training and five days of counselling 
training 
Patient is initiated onto DOT in the clinic 
(takes treatment once a day under 
supervision of the TB nurse)
Before initiating self-administered treatment, the patient 
is placed on DOT in the clinic for a short period (takes 
treatment once a day under the supervision of the TB nurse 
for approximately 2 weeks) to identify problems that might 
preclude self-administration of treatment
Mode of treatment delivery: DOT Mode of treatment delivery: self-administration at home with 
pill counts by treatment supporter
Short information session about TB and 
its treatment given by the TB nurse
Trained lay adherence counsellor gives TB information to 
the participant in 3 - 4 counselling sessions of half an hour 
each, focusing on treatment education, side-effects, healthy 
living and adherence planning and TB and HIV 
No visits are made routinely to patients’ 
homes
A treatment supporter conducts a home visit to document 
the patient’s home circumstances and verify their address. 
TB contacts, immunocompromised persons and children 
under 5 years in the household are also referred to the clinic 
for testing and vaccinations
No meeting of different role-players to 
discuss treatment support
Nurse, adherence counsellor and treatment supporter meet 
to discuss each patient’s eligibility for self-administration
Patient can receive DOT in the 
workplace, at the clinic, or by visiting a 
DOT supporter in the community
Patient can take treatment in the workplace, or at a clinic, 
but can also obtain a one-month supply of tablets from the 
clinic and self-supervise their treatment
If patient is not on clinic DOT, nurse 
sees patient at diagnosis, for DOT, for 
2/3 month sputum and at the end of 
treatment
Nurse sees patient at diagnosis, DOT for two weeks and, if 
the patient is eligible for self-administration, once per month 
until the end of treatment and for 2/3 month sputum and end 
of treatment sputum
If the patient is placed on community-
based DOT, s/he visits a treatment 
supporter once a day to receive 
treatment. Maximum DOT supporter 
caseload is 30 patients per month
If the patient is placed on the ETA model, a treatment 
supporter visits the patient three times in the first week 
and once a week thereafter to monitor treatment taking. 
Maximum treatment supporter caseload is 60 patients per 
month
No formal integration of family or friends 
into the treatment plan
Treatment “buddy” has an important role – s/he attends 
counselling and acts as a support and reminder to the 
patient. The buddy can be a friend, family member or 
neighbour of the patient
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Implementation of the programme
The programme was implemented in two primary health care clinics from October 2006, and in 
three additional primary health care clinics providing treatment for tb from 1 april 2007 to 31 
march 2008. 
once diagnosed, a tb patient would attend four adherence counselling sessions with the 
adherence counsellor – a trained lay health worker. These sessions were guided by a flipchart 
specifically developed for this purpose, which gives information on: (a) TB; (b) TB treatment 
and hiv; (c) adherence planning; and (d) general health issues. all counselling sessions were 
intended to be attended by patients and a “treatment buddy” (a close friend, neighbour or family 
member who lives in close proximity to the patient) who was asked to support adherence in the 
patient’s home during treatment. 
a tb treatment supporter – also a lay health worker – would conduct a home assessment to establish 
whether the home environment was conducive to adherence. Following the four counselling 
sessions, an evaluation meeting was held between the tb nurses; tb treatment supporter and 
adherence counsellor to decide whether the patient would be offered self-administered treatment. 
those patients deemed suitable for the programme received one month’s treatment supply. the 
exclusion criteria were:
•	 patients with substance abuse problems
•	 patients without a permanent place to live
•	 patients who were mentally incapacitated
•	 patients who had drug resistant tb
•	 patients who were on retreatment for tb
•	 patients who could take tb treatment at their workplace
•	 Patients who were transferred to another clinic within the first     
two weeks of treatment
•	 patients who preferred clinic-based treatment
patients were asked to use a calendar to keep track of their adherence at home. the envisaged 
role of the treatment buddy was to give general support to the patients throughout the treatment, 
such as reminding about medication, attempting to solve difficulties in taking treatment, and 
reporting these to the clinic. the tb treatment supporter would visit the home three times in 
the first week and once a week thereafter to discuss any issues that may have emerged and to 
monitor adherence. the patient also visited the clinic tb nurse monthly to be weighed and to 
collect medication. at 2 and 5 months into the treatment smear-positive patients would visit the 
nurse to provide sputum samples.
in order to implement the programme, a trained lay adherence counsellor was employed at each 
clinic, while two were employed at a clinic with caseloads over 1800 patients per year. these 
adherence counsellors were drawn from a pool of existing lay health workers working for the tb/
hiv Care ngo. in addition, lay treatment supporters were employed at each clinic to conduct 
the community-based arm of the programme. they were also employed by tb/hiv Care. 
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the programme initiators proposed that increased support, not having to spend time and money 
in visiting a clinic daily, and a structured plan for adherence would increase patients’ adherence 
to tb medication. in addition, taking patients out of the clinic setting and delivering treatment in 
the community would allow more time for tb nurses to attend to those cases that required more 
attention. 
MEtHODs Of tHIs tHEsIs 
 
qualitative data collection was conducted in english and in isiXhosa. the interviews conducted in 
english were performed by sa, and FgDs and interviews with treatment supporters and patients 
were conducted by experienced Xhosa-speaking assistants with university level training in social 
science. the interviews and FgDs were also translated by these assistants, and further checked 
by another Xhosa speaker. although invited, the assistants declined to be part of the analysis due 
to other study commitments. Debriefing was conducted after each group, about the assistants’ 
opinions and feelings regarding the group and any issues that should be resolved. most interviews 
and all FgDs were digitally recorded and transcribed verbatim. two interviews with one nurse 
were not recorded at her request.
in addition to the interviews and FgDs, participant observation was conducted at steering group 
meetings in which the implementation and planning of the eta was discussed. these meetings were 
attended by the ngo responsible for managing the lay health workers part of the programme; the 
managers from City health, Cape town; and staff representatives from each clinic implementing 
the programme. in addition, facility managers and representatives from the provincial Department 
of health were invited to the meetings. notes were taken during these meetings that were referred 
to in analysis for studies i and ii. in addition to participating in the steering group meetings, sa 
also attended a number of the clinic meetings between nurses, adherence counsellors and staff. 
the clinic environment was observed during these visits and informal conversations were had 
with staff about the programme. this provided insights into the implementation of the programme 
at the participating clinics. the detailed methods of each study are described below and in each 
included article.
Study I: Interviews with programme managers, policy makers and academics
Five programme managers were invited to interviews via telephonic and email contact. all 
programme managers involved in the programme from the start of implementation were asked to 
participate, as they were best placed to discuss why the programme was developed. in addition 
to these interviews, two academics that had over 20 years of experience in tb research were 
approached purposively for interviews. they were best placed to comment on recent developments 
in the field of TB treatment and how these related to past policies.
All interviews were in English and took place in the participants’ offices, beginning approximately 
2 months after implementation. a semi-structured guide was used to conduct the interviews 
(Appendix 1), which was modified during data collection to explore issues that emerged as 
important in influencing implementation of the programme. Data collection continued until data 
were saturated.
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Participants and data collection
Study II: Interviews with TB nurses and adherence counsellors and FGDs with treatment 
supporters
this study focused on professional tb nurses’, adherence counsellors’ and treatment supporters’ 
experiences of implementing the eta. all tb nurses, adherence counsellors and treatment 
supporters involved in the eta were asked to attend interviews or FgDs through a personal 
invitation by sa. a suitable time and place was agreed upon. treatment supporter FgDs for 
two clinics were held at a nearby meeting hall due to space restrictions within the clinics. at 
three other clinics the FgDs were held in a free space at the clinic or in the clinic grounds. all 
interviewees and FgD participants were offered refreshments. in addition, treatment supporters 
were reimbursed for their travel costs. The final number of participants in interviews and FGDs 
is described in table 5 below.
Table 5: Participants and FGDs within each participating clinic
staff category Participantsmale/female
No. of interviews (Int.) 
or fGDs
Professional nurses 1/5 7 Int.
Adherence counsellors 0/5 8 Int.
Treatment supporters 1/63 8 FGDs
In total, 64 treatment supporters attended the FGDs. All adherence counsellors, all but one of the 
treatment supporters and all but one of the nurses were female. the interview and FgD guides 
were similar (appendix 2), and touched on issues relating to experience of implementing the 
intervention, relationships with other staff, relationships with patients, and any challenges or 
positive issues that may have emerged during the programme. 
Study III: FGDs with adherent patients and interviews with non-adherent patients
this study, which focused on patients’ views and experiences of tb treatment, was based on VL[ 
FgDs with patients from two intervention clinics and two FgDs with patients from a comparison 
clinic. in addition, two interviews were conducted with patients who were part of the eta but 
who had not completed their treatment. all patients were sampled using convenience sampling. 
at intervention clinics, treatment supporters were asked to contact all of their patients and to 
invite them to attend an FgD at time and place away from the clinic itself. on the day, patients 
were received by the focus group moderator.
non-adherent patients were contacted by adherence counsellors in collaboration with nurses. 
nurses were asked to inform adherence counsellors when non-adherent patients attended their 
treatment, and adherence counsellors then asked them to participate in an interview. these 
patients were interviewed on the clinic grounds.
at comparison clinics, a nurse was asked to contact all of their patients to invite them to attend 
an FgD, which was held in a central place outside the clinic. 
the FgDs and interviews followed a similar semi-structured guide (see example in appendix 3). 
men and women were included in separate groups. this choice was made due to the recognition 
that women might allow men to dominate the conversation, and because women and men have 
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been reported to have different adherence patterns and health- seeking behaviour when infected 
with tb [144]. in addition, due to tb’s close link with hiv, participants may have wanted to 
raise issues that would not have been discussed in a mixed group. all participating patients were 
given refreshments during the focus group and were reimbursed for travel costs (approximately 
R6/US$1 per person). 
Characteristics of patients who participated in the FGDs are outlined in Table 6.
Table 6: Characteristics of patients participating in FGDs 
Intervention Control
Patients who were not 
adherent on the EtA 
(intervention clinics) 
No. of FGDs/ interviews
No. of participants 3
Men 1
Women
Age (median) 3 (18-3 (18-784 (21-27)
Employed 3 10 0
Married 0
On other chronic medications 1
Median time on treatment 4 months 4 months 4 months
Study IV: Time series study 
this study aimed to determine the impact of the eta intervention on treatment outcomes when 
compared with clinics providing Dot. this study is based on the electronic tb register (etr.net) 
of the five intervention clinics and their five comparison clinics. The five intervention clinics 
were chosen by the City of Cape town, based on their need for intervention. in order to choose 
comparison clinics, the clinics within the City of Cape town which were not part of another 
research project were listed. From these, the clinics most suitable and similar to the intervention 
clinics in terms of tb patient loads and treatment outcomes were chosen. 
all data on tb patients newly registered at the 10 clinics were extracted electronically from 
etr.net from 1 January 2005 to 31 March 2008. The electronic TB register has rigorous quality 
controls implemented by the City of Cape town. the start period was chosen as 2005 since 
there was a change in TB definitions used in the services at the end of 2004. Information on 
patients receiving the eta programme was collected with a separate clinic-based register. this 
information was merged with the intervention database. 
Following extraction, data were cleaned and children under 18 years of age, mDR cases and 
transfers into the facility were removed. the dataset was examined carefully for errors, and a 
quality check was performed based on clinic registers and folders where available. missing data 
were sought in the first instance from the paper-based TB register of each clinic, then from clinic 
patient folders. 
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In total, 192 missing outcomes, representing 1% of the total sample, were identified in the 
dataset between January 2005 to end March 2008. Of these, 109 were in intervention sites and 
83 in comparison clinics. From intervention clinics, 91,7% of these were found and entered, 
and in comparison clinics 75,9% were found and entered. the remainder entered the analysis as 
missing data. 
For quality control purposes an initial sample of five random register entries from each quarter 
for the period April-September 2006 and April 2007-March 2008 were extracted. The total 
number of register entries checked was 200, which represented 2.7% of entries for intervention 
clinics and 4.8% for comparison clinics. these register entries were checked either in the register 
or folder at the clinic, and corrected in the dataset. the quality assurance process revealed 13 
discrepancies between the electronic register and paper-based register or folder, representing 
0.065% of the checked entries.
After removing duplicates, the final dataset included 19 357 patients.
Figure 2 details the cleaning process and the final number of patients included in the study. A 
total of 24 447 patients were registered into the electronic TB treatment register from 1 January 
2005 to end march 2008. after excluding patients who had started treatment elsewhere, mDR 
patients, those under 18 years and double entries, 19 357 patients were eligible for this study. 
of these 19 357 patients, 2519 were eligible for the intervention between 1 april 2007 and 31 
march 2008. 
Figure 2: Patient inclusion into the study
Methods
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table 7 presents the characteristics of the patients included in the study before and after the 
intervention at intervention and comparison sites. 
Table 7: Study participant characteristics
Pre-intervention period 
(Q1 2005-Q1 2007) 
(n=13 524 patients)
Intervention period
 (Q2 2007-Q1 2008)
 (n=5833 patients)
Intervention 
clinics* 
(n=8627)
n (%)
Comparison 
clinics 
(n=4897)
n (%)
Intervention 
clinics* 
(n=3668)
n (%)
Comparison 
clinics 
(n=2165)
n (%)
sex
Males 4792 (55.5) 2741 (56.0) 1923 (52.4) 1211 (55.9)
Females 3835 (44.5) 2156 (44.0) 1745 (47.6) 954 (44.1)
Age Mean age (yrs) 35.2 (SD 11.43) 34.9 (SD 11.3) 35.6 (SD 11.6) 35.5 (SD 10.9)
Patient 
category
New 6068 (70.3) 3397 (69.4) 2518 (68.6) 1457 (67.3)
Retreatment 2559 (29.7) 1500 (30.6) 1150 (31.4) 708 (32.7)
New smear positive 3214 (37.3) 2066 (42.2) 1141 (31.1) 771 (35.6)
site
Pulmonary 6275 (72.7) 3870 (79.0) 2579 (70.3) 1715 (79.2)
Extra-pulmonary 1900 (22) 822 (16.8) 838 (22.8) 318 (14.7)
Both 452 (5.2) 205 (4.2) 251 (6.8) 132 (6.1)
smear result 
for pulmonary 
tb or both 
pulmonary 
and extra-
pulmonary tb
Smear positive 4577 (68.0) 2985 (73.3) 1723 (60.9) 1132 (61.3)
Smear negative 1688 (25.1) 924 (22.7) 975 (34.5) 605 (32.8)
No smear 462 (6.9) 166 (4.1) 132 (4.7) 110 (6.0)
Data analysis
Qualitative content analysis (Studies I-III)
qualitative content analysis can identify either latent or manifest content in text [145]. manifest 
content refers to that content that is visible and obvious, whereas latent content refers to that 
content that is the issue that the text talks about, the underlying meaning of the text [145]. While 
both the manifest and latent level of analysis requires interpretation, it could be said that the latent 
level of analysis would require further abstraction, as being more in-depth and requiring more 
interpretation than the manifest level of analysis [145]. 
qualitative content analysis was conducted using the principles of graneheim and lundman [145]. 
the transcripts of each FgD or interview were considered the unit of analysis. First the transcripts 
were read and reread to gain familiarity with the data and a sense of the whole. Following this, 
each transcript was coded openly, identifying phrases, words and sentences that formed meaning 
units. these were then condensed into condensed meaning units. these condensed meaning units 
were then abstracted further, and labelled with a code. in study i codes were further arranged 
according to sub-themes and major themes, as the level of abstraction was increased and the 
analysis examined the latent content of the interviews rather than staying at the manifest level of 
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analysis [145]. in studies ii and iii, codes were assigned to sub-categories, following which the 
sub-categories were classified into categories [145].  
in study iii, the initial coding was done independently by a co-researcher (Db), a student in public 
health, and sa. sa, Db, and sl then met to discuss these codes. after this, sub-categories and 
major categories were generated. these were then presented to the full study team and discussed. 
in studies i and ii, the initial codes were read by the whole study team. after this, sa generated 
sub-categories and categories, or sub-themes and major themes. these were discussed among the 
study team. in order to organize and make sense of the results, as well as to make recommendations 
for further action, the major categories in study ii and major themes in study i were organized 
according to existing theoretical models. 
Study I utilized Kingdon’s model of agenda setting [146]; this model is useful for identifying those 
factors that lead to an issue being placed on policy makers’ agendas. the model suggests that three 
different streams need to come together at a certain point to enable an issue to reach the policy 
agenda: the problems stream - perceptions of problems as public matters requiring attention; the 
policies stream (or solutions to the problem) - ongoing analysis of problems and their solutions and 
the debates and discussions surrounding them; and the politics stream - which includes the local 
and national mood, elections, or pressure from interest groups. the three streams are independent 
of one another, and flow in parallel. The coming together of these streams can lead to the opening 
and closing of policy windows, or opportunities for shifting an issue onto an agenda. Further detail 
on this model can be found in article i. 
Study II used the normalisation process model [116], which was designed for understanding the 
processes of implementing a complex intervention, and understanding how interventions become 
workable and integrated into everyday work. the model has four main constructs and eight 
categories. the constructs are as follows: interactional workability, examining how the programme 
affects interactions between people and practices; relational integration, which examines how the 
programme relates to existing concepts and relationships; skill set workability, which examines 
how the division of labour is affected by the intervention; and  contextual integration, which 
concerns how the intervention relates to the existing organization and practices. Further detail on 
this model can be found in article ii. 
Statistical analysis (Study IV)
Outcome variables for TB treatment were defined using the WHO standard outcomes (see Table 
8). For smear-positive patients, analysis was conducted on smear conversion at 2 months; smear 
conversion at 3 months; and cure and treatment success. smear conversion at 3 months was 
included in the analysis because this would include patients who smear converted, but who had 
their smear test later than 70 days into their treatment. For all patients analysis was conducted on 
treatment success at the end of treatment. 
Descriptive statistics were generated for all the outcomes, and for patient characteristics. 
aggregated data for each clinic and quarter were analysed, resulting in counts for each response 
variable. this was transformed into a ratio from total patient numbers at a clinic in a given 
quarter. a poisson regression model was used to analyse the data. variables indicating whether 
the observation was pre- or post-intervention, and another indicating whether the clinic belonged 
to the comparison or intervention group, were created. A significant interaction between these 
two variables indicated a change in the rates, i.e. the relative change in rate between intervention 
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and comparison sites. We used a generalized estimating equations (gee) model to account for 
the correlation between the responses from the same facility, using the first-order autoregressive 
(AR(1)) structure. Results were reported as incidence rate ratios, with 95% confidence 
intervals.
Table 8: Terms used in the study and their definitions (adapted from [36])
term Definition 
Case of TB A patient in whom TB has been confirmed by bacteriology or diagnosed by a clinician
Definite case
A patient with positive culture for the Mycobacterium tuberculosis complex. In 
countries where culture is not routinely available, a patient with one sputum 
smear positive for acid-fast bacilli (AFB+) is also considered a definite case
Pulmonary case A patient with tuberculosis disease involving the lung parenchyma
Smear-positive 
pulmonary case
A patient with one or more initial sputum smear examination/s (direct smear 
microscopy) AFB+
Smear-negative 
pulmonary case
A patient with pulmonary TB not meeting the above criteria for smear-positive 
disease. Diagnostic criteria should include: at least two sputum smear 
examinations negative for AFB; and radiographic abnormalities consistent with 
active pulmonary TB; and no response to a course of broad spectrum antibiotics 
(except in a patient for whom there is laboratory confirmation or strong clinical 
evidence of HIV infection); and a decision by a clinician to treat with a full course 
of antituberculosis chemotherapy; or positive culture but negative AFB sputum 
examinations
Extrapulmonary 
case
A patient with TB of organs other than the lungs (e.g. pleura, lymph nodes, 
abdomen, genito-urinary tract, skin, joints and bones, meninges). Diagnosis 
should be based on one culture-positive specimen, or histological or strong 
clinical evidence consistent with active extra pulmonary disease, followed by a 
decision by a clinician to treat with a full course of antituberculosis chemotherapy. 
A patient in whom both pulmonary and extra pulmonary TB has been diagnosed 
should be classified as a pulmonary case
New case A patient who has never had treatment for TB or who has taken antituberculosis drugs for less than one month
Retreatment 
case
A patient previously treated for TB, who is started on a re-treatment regimen after 
previous treatment has failed (treatment after failure), who returns to treatment 
having previously defaulted (see below; treatment after default), or who was 
previously declared cured or treatment completed and is diagnosed with 
bacteriologically positive (sputum smear or culture) TB (relapse)
Cured A patient who was initially smear-positive and who was smear negative in the last month of treatment and on at least one previous occasion
Completed 
treatment
A patient who completed treatment but did not meet the criteria for cure or failure. 
This definition applies to pulmonary smear-positive and smear-negative patients 
and to patients with extra pulmonary disease
Died A patient who died from any cause during treatment
Failed A patient who was initially smear-positive and who remained smear-positive at month 5 or later during treatment
Defaulted A patient whose treatment was interrupted for 2 consecutive months or more
Transferred out A patient who transferred to another reporting unit and for whom the treatment outcome is not known
Successfully 
treated A patient who was cured or who completed treatment
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 EtHICAl CONsIDERAtIONs
ethical approval for all studies was obtained from the medical Research Council of south africa, 
and the Centers for Disease Control, atlanta, united states. approval for the study was obtained 
from City health, Cape town, and facility managers at each clinic. a challenge to obtaining ethical 
permission to conduct the study was the use of age groups in tb reporting. standard tb reports in 
Cape town include children over the age of 15 in the adult cohort, since their treatment is the same 
as that for adults. however, this was not acceptable to the ethical Committee, and the age limit had 
to be raised to 18 years. 
all participants in qualitative interviews or FgDs were given an explanation of the study in a 
language with which they were comfortable. Written informed consent was received from each 
participant. participants were not paid, but were given refreshments and their travel costs were 
reimbursed.  participants were also told they were free to stop the interview at any time, and were 
free not to participate at all. 
At FGDs participants were asked to maintain confidentiality and not reveal topics of discussion 
outside the group. patients were reassured that participating in the FgD would not affect their 
treatment in any way. at the start of one FgD two men who had arrived for the discussion departed 
without participating. this suggested to the research team that there was at least some awareness 
of their rights, and ability to act on these, among participants. 
at the comparison clinic nurses invited patients who attended the clinic for treatment to join the 
FgD. this was initially a concern, because the research team considered that patients may have 
interpreted the FgD as part of their treatment. however, the purpose of the FgD was clearly 
explained to each participant. the criticisms of the clinics that emerged in these groups suggested 
that participants did not perceive the FgD moderator as part of clinic staff.
nurses and lay health workers were assured that participation or non-participation would not affect 
their employment or working conditions. individual informed consent was not required for the 
quantitative component, since individual patient data were made anonymous and the study did not 
interfere with the usual treatment provided by the health services.
several ethical challenges arose during the process of conducting the study. Firstly, conducting 
it required a fine balance between being useful for programme managers and maintaining the 
confidentiality of interviewees. The managers would at times ask questions about programme 
progress at clinics, and while general indications of process issues could be given – for example, 
that there was a need for a particular resource, such as a treatment calendar, at a particular clinic, 
care was taken not to reveal the particular opinions of any of the participants to management. 
Secondly, issues discussed in FGDs could not be maintained as confidential, although emphasis 
was placed on the need for confidentiality and keeping issues discussed within the group, since 
FgD participants could recognise each other in the clinic or in the community. 
however, the range of personal experiences reported in the patient FgDs suggested that participants 
were comfortable sharing their experiences with each other. When asked how they experienced 
the FgD, most participants reported that they appreciated having a forum in which to share their 
experiences.  
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resuLts
this section provides a summary of results from the study. the focus is on the development of 
the programme, its implementation, effects on patients’ experience of tb treatment, and impacts 
of the programme on treatment outcomes. 
wHy wAs tHE EtA DEVElOPED? (stuDy I)
study i indicated that although there have been considerable challenges to tb control over the 
years, the approach to treating tb through supervision has remained more or less unchanged. 
Since 1996, South African policy has demanded that all patients undergo treatment under 
DOT, for the full 6-month duration. There were a number of problems within the TB treatment 
programme in the study setting – patient loads were high, hiv co-infection was high, treatment 
outcomes were poor, and, unofficially, patients were given tablets to take home. However, these 
problems had been present in the tb control system for a long time. 
In Study I the key issues influencing the development and implementation of the ETA were 
identified. These included considerable problems within the TB control system; an available 
model to use in the form of the aRt programme; and the political climate being ready for a 
change. these, in combination with the presence of key individuals, made the programme 
possible. Further detail on these key issues is presented below. 
Problems that influenced development of the ETA
the problem driving the development of the eta was that the existing model of tb control was 
not working. this was seen to be closely related to large case loads, overcrowding in clinics, and 
the overloading of staff. according to participants, the Dot component was designed for small 
caseloads and was no longer appropriate due to the hiv epidemic: 
“But I am 100% convinced that we can’t carry on using 
the same old model in these new days” (programme manager 2) 
in addition, there was a perceived need to improve management of the programme. Respondents 
in the health services noted that  there was a large number of Dot supporters (a form of lay 
health worker), and that they viewed the Dot supporters’ management system as ‘loose’ in that 
Dot supporters reported to the participating ngo supervisors, but were not accountable to the 
clinic. Another perceived problem was that the current programme had insufficient focus on 
people, and instead was rather mechanical and focused on treatment outcomes. participants also 
contested the benefit of all patients attending the clinic or visiting a lay health worker for treatment 
observation:
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“And what is the real benefit of watching people? The real benefit of watching people, 
in my view, is not at all confirmed because I remember in some clinics where we saw the 
patients, passing by the clinic, waving us goodbye, and they were supposed to come to 
be watched swallow the medication!  But they didn’t come.  What do you do?  You go 
running after them?  You open their mouths and stuff the tablets down their throat?” 
(programme manager 2) 
one of the largest issues driving change, however, was the co-epidemic of tb and hiv. hiv was 
increasing patient numbers, and a large percentage of patients were co-infected. at the same time, 
treatment outcomes were perceived as being better in the aRt programme than in the tb control 
programme. 
the proposed solution
the aim of the eta programme, as outlined by respondents, was to improve treatment outcomes 
through implementing a patient-centred or empowering approach, and through better teamwork 
between nurses, adherence counsellors and treatment supporters at the clinic. modifying the 
aRt programme for use in tb treatment was seen as a way to provide solutions for problems 
surrounding human resources in the tb programme, and to give patients treatment in a manner 
more suited to them. however, participants recognized that it was not a ‘cure-all’ for the problems 
outlined above. 
the aRt model also provided a different way of managing lay health workers:
“Because I think in the past, what we’ve done is we’ve come to devolve all responsibility 
to [the relevant NGO] – and you can’t really do that.  You know, the line management still 
kind of has to be … accountability has to lead back to the clinic” (policy maker 1) 
management and accountability could be improved through increasing teamwork between facility 
staff and lay health workers, and by asking lay health workers to document their work. including 
more skilled lay health workers that were managed more strictly, and an additional cadre (adherence 
counsellors) that helped to ensure that patients understood the treatment requirements of the tb 
treatment programme, was seen as allowing professional staff to concentrate on problem cases 
and on their administrative work. however, participants lamented that this often meant losing 
the more dedicated, older cadre of lay health workers. they were also concerned about how the 
system would allow for monitoring of lay health workers’ work in the community:
“..who exactly is going to manage the performance of the treatment supporter to make 
sure that they provide the support to the patient, if it’s needed for them to adhere to their 
treatment?” (programme manager 4)
participants also saw encouraging teamwork between the different cadres and clarifying roles as 
potentially reducing the distrust between lay and professional health workers. 
some respondents also discussed the potential of using this model to better integrate tb 
treatment with other treatment programmes, through the use of one lay health worker to provide 
comprehensive services for one household. 
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the political backdrop
the Western Cape’s history of academic research on the effectiveness of the tb control 
programme and of contesting policies developed at national level was a political backdrop 
perceived by participants as facilitating piloting of the programme. the wider political 
movements within South Africa also seemed to influence the development of the programme. 
empowerment of communities was on the government agenda, and tb control was seen as 
particularly disempowering by some participants:
“[the] whole move has been towards empowering people on the ground, 
and the TB system in particular was a very disempowering one.  It was  
kind of based on the mentality that we as health professionals know best.   
We will tell you what to do and when to do it – and you just follow directions.   
And there wasn’t really very much accommodation made for what patients’ needs …  
or people talked about a client-centred approach, but a client-centred approach that 
suited the health system” (policy maker 3) 
a national community or lay health worker policy was also being developed, that would call for 
community or lay health workers to do more than one task in the community, instead of focusing 
only on one disease. there was a:
“…call from the national health department that people in organisations with vertical 
programmes would not be funded… had to start working as an integrated model of  
care where one carer would address all the problems of a particular person” 
programme manager 4) 
Another influence was the growing ART programme. There was a need to rapidly expand ART, 
which had further implications for human resources for health, and therefore for the tb programme. 
Respondents highlighted problems of sustainability and affordability with regard to disease-specific 
interventions, suggesting that more integrated approaches were more sustainable: 
“..but I can’t see with six million people needing ARVs in the next three to four years, 
how else we’re going to do it … before we can even afford the ARVs.” (policy maker 2) 
The political influences seemed to impact on participants’ examination of the problems within the 
tb treatment programme and search for solutions. all these three factors were, however, brought 
together by “champions”, who also had access to programme information from other disease 
programmes. 
more detailed information on these issues can be found in article i. the next section describes staff 
perspectives of implementing the eta. 
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wHAt wERE tHE kEy IssuEs tHAt INfluENCED tHE IMPlEMENtAtION Of 
tHE EtA fROM stAff PERsPECtIVE? (stuDy II)
Influences on the implementation of the ETA were obtained from interviews with nurses and 
adherence counsellors and FgDs with treatment supporters. the results were categorized 
according to elements of the normalization process model [116]. In terms of interactional 
workability, which refers to the programme’s effect on interactions between programmes and 
practices, the main issues to emerge as impacting on implementation were the content of work 
and staff roles within the eta (congruence) and perception of goals and effects of the eta 
(disposal). 
in terms of relational integration, which refers to existing knowledge and relationships, the main 
influences were the additional knowledge required by the programme (accountability) and the 
general credibility of the programme (confidence). 
in terms of skill-set workability, which refers to the effects of the programme on division of 
labour, the main issues were task allocation and skills (allocation), and staff capacity to implement 
the eta (performance).  
Finally, in terms of contextual integration, which refers to the programme’s relation to the 
organization in which it is set, the main issues related to resource requirements (execution) and 
modifications to practices and resources (realization). Each of these issues is discussed briefly 
below. 
Interactional workability: Content of work, staff roles and perception of goals and 
effects
staff had been assigned clear roles at the start of the programme. Despite this, adherence 
counsellors reported performing duties outside their set tasks, such as directing patients in the 
waiting area to correct treatment rooms. the main change in content of work was that a more 
empowering approach needed to be taken – however, nurses and adherence counsellors did not 
feel that a major change had been made, and continued to express patronising attitudes towards 
patients:
“[The patient is] Like a child, you tell him you are going to buy sweets, 
but you don’t buy it.  Then they cry because they lose faith” (nurse) 
nurses also described patients as unreliable and untrustworthy. it also seemed that adherence 
counsellors and treatment supporters wanted to maintain a higher status for themselves in 
comparison to the patients, and made a number of remarks that suggested that they were not 
equals with patients.
in terms of the goals and effects of the programme, not all staff were convinced that the programme 
would be beneficial.  Although they could identify a number of benefits of the programme, 
such as reduced queues and easier follow-up, they continued to question patients’ adherence and 
suggested that the Dots approach helped in patient monitoring:
“To add on DOTS was [better] than [the ETA] because you as a health worker 
knew for sure that the patient is taking the pills – now, even though there is someone 
responsible for the patient, there is no way of knowing” (clinic 4)
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Relational integration: Credibility of the programme and the need for additional 
knowledge 
staff needed to learn the processes of the programme and new administrative procedures. 
training sessions were conducted for all, but some nurses had not attended them and some felt 
they had not paid as much attention as they might have if they had been directly involved with 
the eta at the time of training. this created some apprehensions regarding the programme and 
being responsible for implementing it:
“… I think for the [lay health workers] they are doing the training, but for us nurses, 
I haven’t been trained and I’m supposed to supervise.  What am I supervising if I don’t 
know anything about the [ETA]?” (clinic 4)
the gaps in training and perception among some nurses that lay health workers knew more about 
the programme than they did, also created some strain in working relationships. While some 
nurses felt that lay workers were trained adequately for the programme, others doubted whether 
the training had been sufficient.
another hindrance to implementation of the eta may have been staff attitudes towards it, and 
their perceptions of its credibility. not all nurses felt that an hiv model would be appropriate for 
tb, and some felt that patients could be confused if they went through two separate education 
sessions. they did feel, however, that patients liked the eta better than the previous Dot model, 
and most perceived the eta as a good programme for patients.
skill-set workability: task allocation and capacity to implement the programme
tasks were allocated to staff by management. there remained, however, a hierarchical working 
relationship between different cadres of staff. this affected treatment supporters the most, and 
they seemed to resent their treatment by other staff and their status at the clinic.  nurses and 
adherence counsellors also seemed to have little faith in treatment supporters’ abilities, although 
they held them responsible for the success or failure of the programme:
“... So if it didn’t work then they [the treatment supporters] must know it’s their baby – 
it’s their fault that it didn’t work.  Yes, it is their fault because they are the ones who go 
to the clients.  They are the ones who bring back the feedback to the clinic.  Is the client 
taking treatment every day? What did they see? So they come back and report to us.” 
(adherence counsellor)
initially all staff also expressed uncertainty regarding implementation of the programme, 
and whether they would be able to carry it out. initially staff also complained regarding the 
administration they had to do. later some staff appreciated the time for administration they 
now had because patients were not at the clinic but out in the community. however, treatment 
supporters also encountered a number of challenges when visiting patients, such as gaining entry 
into the home, crime and patients’ or their families’ substance abuse. 
one of the largest challenges to staff capacity to implement the programme was hiv. adherence 
counsellors and treatment supporters especially reported having to answer questions about hiv 
when dealing with patients. this also created complications when treatment supporters visited 
families in the community: 
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“…at times it is your patient who is HIV [positive] and now it feels like you asking him/
her to tell the whole family.” (treatment supporter)
most staff expressed further training needs. nurses expressed training needs in terms of programme 
implementation, while adherence counsellors wished for training on hiv and its treatment. 
treatment supporters wished for more training on the administration of the programme and hiv-
related issues.  
Contextual integration: Resource requirements and modifying practices and 
resources
the issues related to resources and practices centred mainly on funding for lay health worker 
stipends and lack of space at the clinic. Funding needed to be arranged for stipends, and the flow 
of resources from the City to the participating ngo meant that payments were sometimes late. 
this created considerable frustration among treatment supporters:
“They are robbing us, they take their time to give us our money, they make promises 
they can’t keep, and they hardly support us with our needs. We know we are regarded 
as volunteers but they promised to give us little something to motivate us but ... we are 
struggling. We always keep up with our work because should we not they shout at us.” 
(clinic 3)
lack of space for counselling was another issue that complicated implementation. adherence 
counsellors had to counsel in storage and filing rooms, which may have impacted on the 
confidentiality and privacy of counselling. 
Other modifications to resources included a dedicated project manager, who gave hands-on help 
to all the participants in the programme. Her participation was seen as a positive influence on 
implementation, and staff reported turning to her with their problems regarding day-to-day running 
of the programme. one of the main challenges, however, was lay health worker attrition, as both 
some adherence counsellors and many treatment supporters left the programme. new treatment 
supporters could not be trained, so as not to create an expectation of employment. 
Staff identified a number of constraints to implementing the programme, but appeared to view it 
positively and felt that patients appreciated it. Resource constraints impacted on the implementation 
of the programme. 
the next section examines the effect that the eta had on patients’ experiences of tb treatment. 
HOw DID tHE EtA AffECt PAtIENts’ ExPERIENCEs Of tb tREAtMENt? 
(stuDy III)
Overall, findings from Study III suggested that patients from intervention clinics were more 
positive towards tb treatment than patients from comparison clinics. intervention clinic patients 
also reported having constructed routines around their treatment taking: 
“I wake up and take my pills, then clean and then eat …” (male participant, 
intervention)
38
intervention clinic patients also spoke of the treatment necessitating lifestyle changes, and that 
they had embraced a healthier lifestyle: 
“… you should not smoke, you should not drink and you should not default your 
treatment” (male, intervention)
some said that initially they had not succeeded in making these changes, but had been ‘caught up 
on’ by treatment supporters. issues related to lifestyle changes were reported less in comparison 
clinic focus groups, with some male patients reporting that some of the group had surely been out 
drinking, the night before, and emphasising that people needed to be educated on their treatment. 
the male interviewee who had been recalled to clinic treatment due to poor adherence reported 
that one of the influences on his non-adherence was taking up drinking and smoking again, and 
therefore becoming ‘lazy’ to go to the clinic for check-ups. 
patient empowerment was used as a central concept in the programme. it seemed that intervention 
patients had heard these issues during the counselling and, following from this, expressed their 
reasons for remaining on treatment as ‘taking responsibility for their health’, ‘loving themselves’ 
and ‘taking care of themselves’: 
“I think people should learn to value themselves and their lives and then they will not 
stop taking their treatment. People have to love themselves so much that they do not 
need [a] caregiver to run after them to take their treatment” (female, intervention) 
although intervention patients emphasised the need to take responsibility and control over their 
treatment when speaking about themselves, their suggestions to encourage other non-adherent 
patients to take their treatment were at times extremely coercive. among others, these included 
hospitalization and Dot by a treatment supporter. 
a prerequisite for being on the eta was to have a treatment supporter visiting, and assigning a 
treatment buddy from the home or neighbourhood to support the patient in taking treatment. in 
comparison clinics, most patients visited a local treatment supporter for their daily treatment. 
participants receiving the eta intervention expressed a range of responses to their treatment 
supporters. initially, most patients were suspicious of their treatment supporters’ motives, but 
later appreciated this relationship and even reported that treatment supporters were people who 
took care of them. however, comparison clinic patients, especially men, reported more distrust 
and suspicion toward their treatment supporters, while women seemed resigned that having a 
treatment supporter was part of tb treatment. the relationship between treatment supporters 
and patients did not seem to develop into friendship – interactions between patients and their 
treatment supporters were limited to discussing treatment.  
patients from intervention groups mostly appreciated the support they got from their buddies. 
the two patients who had been recalled to clinic treatment from the programme reported 
problems with their buddies as one of the reasons they had not remained adherent. however, the 
buddies also seemed to have a limited role to play, since some intervention participants reported 
that buddies did not care whether treatment was taken or not. some also felt that their family 
relationships had become strained after selecting a person as their buddy. 
some intervention clinic patients also reported that their buddies had taken on a supervisory role 
in treatment: 
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“... she does not only remind me to take my treatment she makes me take it right in front 
of her”
This seemed to conflict with the intention of the new programme. 
overall, the intervention seemed to be received positively by patients, and patients from 
intervention clinics expressed positive opinions of tb treatment. the responses to and activities 
of buddies and treatment supporters were mixed. 
the next section examines the impact of the eta on treatment outcomes. 
wHAt IMPACt DID tHE EtA HAVE ON tb tREAtMENt OutCOMEs? (stuDy IV)
in study iv, a total of 19 357 patients met the inclusion criteria for the time series analysis. 
table 9 presents treatment outcomes for intervention and comparison clinics before and after the 
implementation of the programme. 
Table 9: Treatment outcomes for intervention and comparison clinics
Pre-intervention period 
(Q1 2005-Q1 2007)
Post-intervention period 
(Q2 2007-Q1 2008)
Intervention
n (%)
Comparison
n (%)
Intervention
n (%)
Comparison
n (%)
Cured 2774 (32.2%) 1808 (36.9%) 1144 (31.2%) 754 (34.8%)
Completed 3331 (38.6%) 1720 (35.1%) 1536 (41.9%) 860 (39.7%)
Failed 85 (1%) 48 (1%) 32 (0.9%) 27 (1.3%)
Defaulted 1582 (18.3%) 661 (13.5%) 588 (16%) 240 (11.1%)
Transferred 364 (4.2%) 258 (5.3%) 136 (3.7%) 114 (5.3%)
Died 482 (5.6%) 380 (7.8%) 224 (6.1%) 165 (7.6%)
Not evaluated 9 (0.1%) 20 (0.4%) 8 (0.2%) 5 (0.2%)
Total 8627 (100%) 4897 (100%) 3668 (100%) 2165 (100%)
The regression analysis showed that there was a significant difference in smear conversion rates 
at 2 and 3 months, between intervention and comparison sites (iRR: 1.08, Ci:1.00-1.17 for 
2-month smear conversion and iRR: 1.08, Ci: 1.02-1.14 for 3-month smear conversion). 
There was no significant difference in the cure (IRR: 1.03, CI 0.92-1.15) and treatment success 
(iRR: 1.01, Ci 0.94-1.09) rates for smear-positive patients in the intervention and comparison 
clinics. There was also no significant difference in treatment success rates for all patients, 
including retreatment and smear-negative patients (iRR: 1.01, Ci: 0.94-1.09). 
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discussion
MEtHODOlOGICAl CONsIDERAtIONs
Evaluation research
programme evaluations can provide useful feedback for management and administrative 
purposes; can support the oversight activities of funders, sponsors and authorities to which the 
programme is accountable; and can accurately depict programme activities and accomplishments 
to advocates, adversaries, clients and other stakeholders. they may also contribute information 
for planning and policy purposes by indicating whether the approach is worth pursuing or by 
demonstrating the usefulness of a professional practice [147].
the framework for evaluating complex interventions to improve health suggests that evaluating 
the effectiveness is a four-stage process, the last one of which is a definitive randomized 
controlled trial (RCT) [148]. The evaluation that frames this thesis could be seen to fit within 
phase two of this process, in which the acceptability and feasibility of the intervention under 
study are evaluated. evidence-based approaches suggest that RCts are the best way to establish 
effectiveness [149]. however, RCts or other methods of establishing effectiveness, such as the 
time series study discussed in this thesis, do not always highlight those areas of the strategy that 
have made the desired impact [150], or those parts that failed or prevented the intervention from 
making an impact. 
in contrast, process evaluations provide insight into the processes and mechanisms through 
which an intervention achieves its effects [150]. using qualitative methods, such as those used 
in this thesis, can produce valuable information on how things worked in the programme, which 
then enables making recommendations on how parts of the programme can be altered [115]. 
the process evaluation which frames this thesis assists in gaining insight into how this model 
could be implemented in other settings, a key issue in intervention research [151]. it includes 
and examines the perspectives of staff and patients, which are integral to assessing the overall 
intervention since an intervention that is not acceptable to the end user or the implementers may 
be unsuccessful [152]. 
sa was part of early meetings discussing the possible implementation of this study. therefore, 
the evaluation questions and broad methods were decided in collaboration with City health, 
Cape town, in accordance with utilisation-focused evaluation [153], and the resulting articles 
were used in this thesis. however, conducting research on a programme implemented by others 
at their request places limitations on the time and methods available [115]. For example, in study 
iv randomisation was precluded because the authorities selected the clinics to receive the new 
programme. 
the evaluation that frames this thesis was conducted from a participatory framework [115], 
which both strengthened the understanding of the intervention and its processes, and presented 
challenges in performing the evaluation. members of City health had the opportunity to comment 
on the findings of the research, but did not take part in the analysis of results. In addition, SA took 
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part in steering group meetings that discussed planning and implementation of the intervention. 
although an attempt was made to take a less active and more observational role in the meetings, 
participatory evaluation can result in complications due to issues similar to those facing action 
researchers doing research in their own organization (for example, political relationships within 
the organization, role conflict and role duality [154]). Role duality can affect the data, in that 
relationships with some members of the organization would affect relationships with others, 
and thus alter the data [154]; for example, the interviews at clinics may have been affected by 
the interviewer’s relationship with programme management. in addition, role duality resulted in 
being part of both evaluating and implementing the programme, through needing to be useful to 
the implementers and, for example, delivering resources during clinic visits or designing forms 
used in the intervention. 
study designs
this thesis utilised mixed methods in establishing both what is happening and why it is happening 
in the way that it is [155]. the strength of using mixed methods is that the results from qualitative 
and quantitative studies complement each other [155]. the disadvantage, however, is that at 
times treatment of the results of one or the other may be superficial and results may not be 
completely integrated [156].  In this thesis, qualitative and quantitative results complemented 
each other, although it was difficult to link them explicitly to each other. While quantitative 
results provided information on the effects of the programme, qualitative results highlighted 
issues related to implementation and the experiences of both staff and patients. studies i to iii 
explored the human and social experience related to the eta, especially related to interaction, 
relations, development, interpretation and activity [157, 158]. 
study iv used an interrupted time series design to estimate the effectiveness of the new intervention. 
the inclusion of comparison clinics added to the strength of the design [117], since these could 
control for the effects of policy changes or other improvements occurring at the same time as the 
intervention. interrupted time series designs are the strongest quasi-experimental designs, and 
a good alternative when randomisation is precluded [117]. in this study, the time series design 
allowed for estimating the effect of the intervention, taking into account the continuing trend of 
improvement over time. 
Qualitative methods
Benefits and limitations of interviews and FGDs
there were a number of key issues that related to the use of interviews and FgDs in studies i-iii. 
some of these are outlined below.
interviews were used in studies i-iii since they are useful when wanting to elicit individual 
experiences and opinions on sensitive topics [159]. in this thesis interviews allowed the participants 
to express their opinions in their own terms. therefore, issues such as rank between nurses could 
not impact on how participants told of their experience of implementing the programme in study 
ii. however, some nurses experienced the interview as stressful, and felt they were being tested, 
despite assurances to the contrary. this could have resulted in these nurses holding back some of 
their experiences or more forceful negative opinions of the programme.
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The interviews were also conducted in English, and though all participants were fluent in it this 
was not all of their first language, and therefore may have prevented a more nuanced description of 
their experience. interviews functioned well when dealing with the development of the programme 
(study i) and the opinions of management, who were more comfortable in a one-to-one setting. 
interviews were also conducted with two patients who had been non-adherent in the programme; 
this was most appropriate since locating a number of recalled patients to a FgD would have been 
difficult.
FgDs were conducted with patients (study iii) and treatment supporters (study ii).  the advantage 
of FgDs is that a range of responses can be captured at the same time, persons who may not feel 
comfortable in a one-to-one setting may be included and participants can share experiences [160]. 
However, group dynamics and relations between different people can influence the results. In 
patient FgDs it seemed from reports of the focus group moderator that everyone could contribute 
to the discussion, and a range of opinions - even conflicting - were expressed. However, this 
issue was more complicated in treatment supporter FgDs, where group dynamics resulted in older 
females dominating the conversation, and discussions were steered towards extensive discussion 
about payment problems, despite the FgD moderator’s attempts to counter this. 
Participants and sampling: Studies I-III
the participants in study i were those programme planners and implementers that were 
involved in the programme from the start. in addition, academics and policy makers involved 
in tb control for some decades were included purposively. purposive sampling, in this case 
purposive stakeholder sampling, implies selecting those participants that are best able to answer 
the question at hand [161]. Although all but one of the participants were female, this was not a 
conscious choice; rather, those participants who were available and had suitable experience were 
selected for interviews.
Sampling for Study I followed the data saturation principle in grounded theory [162], which 
meant that more data were collected as analysis progressed, and when no new themes seemed 
to emerge from interviews, data collection was stopped. This approach, although beneficial in 
limiting the number of interviews, could mean that some individuals who may have had a different 
view of the development of the intervention were not included in interviews. individuals who 
could inform this study were limited in number, but a substantial proportion were included in the 
analysis. 
in study ii all nurses, treatment supporters and adherence counsellors were asked to participate. 
While none explicitly declined, two nurses would not keep their appointments or made it difficult 
to make an appointment. after at least two attempts, this was considered declining to participate. 
although nurses, adherence counsellors and treatment supporters were invited personally to 
interviews and FgDs, and it was assured that non-participation would not translate into sanctions 
at their workplace, they may have attended because they thought it part of their jobs. however, 
the range of negative opinions expressed at these FgDs and interviews suggested that they were 
comfortable in expressing their opinions. 
participants for FgDs in study iii were invited through treatment supporters in intervention 
clinics, and clinic staff in comparison clinics. although all patients were invited, there is a 
possibility that treatment supporters encouraged those with whom they had better relationships 
to attend FgDs. this may have resulted in a more positive impression of the programme. 
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Using theoretical models within qualitative research
one of the strengths of the evaluation discussed in this thesis was the use of additional theory 
to disentangle the programme effects. The normalisation process model [116] used in Study II 
assisted in establishing those areas of the intervention that were beneficial, and those that hampered 
the implementation of the intervention, and can inform judgements about the probability that a 
complex intervention will become routinely incorporated in practice.
studies i and ii used theoretical models to organise the results of qualitative content analysis. 
this type of organization is unusual in qualitative research and could be seen as a combination of 
inductive and deductive analysis.  
the analysis in studies i and ii progressed in stages. initially, main categories were created through 
qualitative content analysis, after which these were examined for how they fit within the constructs 
of the model. In Study I, which utilized Kingdon’s model of agenda setting [146], the approach 
was more inductive. When the results were examined in relation to this model, it was realized 
that some key aspects that may have resulted in policy change, in particular information on the 
political context, was missing, and further interviews were conducted in order to inform this gap. 
The model was therefore of benefit in examining the way in which policy change came about, and 
allowed for a more comprehensive picture of the phenomenon than would have emerged through 
the use of qualitative content analysis alone.  
study ii used the normalisation process model to contextualize results. a similar approach was 
undertaken for analysis, in that initially qualitative content analysis was performed, and the major 
categories that emerged were examined for their relation with the normalization process model 
[116].  In this case, some issues that would have had a more strong representation in the results, 
such as teamwork and hierarchy, were emphasised less in the model, while issues that did not 
initially emerge as key to implementation were given attention. having the model part of the 
analysis enabled making suggestions on key issues that should have been paid attention in order 
for the programme to become part of clinic routine. these suggestions would have been more 
difficult to make based on thematic content analysis alone. 
This aspect, while perhaps unconventional in qualitative research, was of benefit in examining the 
intervention and having the results present more practical suggestions for improvement in order to 
implement this programme on a wider scale.
Validity
triangulation implies comparing the results of two or more methods or two or more data 
sources to corroborate an overall interpretation [163]. In addition to qualitative and quantitative 
methods complementing each other, triangulating through involving researchers from different 
backgrounds in analysis was particularly useful in this thesis  [164]. It enabled discussions that 
strengthened the analysis of particularly qualitative data in studies i-iii, and countered the 
influence of preconceptions. Quotes included were also intended to increase the validity of the 
findings, by allowing the reader to estimate the validity of the interpretation.
main threats to validity were the impact of the interviewer or focus group moderator being part 
of the health services, and using translated material in analysis. although the perception of being 
44
part of the health services or of reporting back to others more senior in the health services did not 
impact in study i, it could have impacted on the data in studies ii and iii. as suggested earlier, 
patients may have thought that the FgD moderator was part of the health services and that the 
FgDs were compulsory. however, the range of negative opinions expressed suggested that this 
was not the case. 
in study ii, nurses and adherence counsellors more than treatment supporters may have been 
influenced by the perception that the interviewer was part of the health services, since their 
responses to the programme seemed more positive and sa conducted the interviews. however, 
it is unlikely that this influence impacted on the data to a great degree. 
one of the main threats to validity is using translated material in analysis, and not including a 
Xhosa speaker in analysis. the FgDs were translated by the FgD moderator, who was considered 
competent as a bilingual social science university graduate [165].  The translations were later 
checked for accuracy by another bilingual community member. however, having a person who 
would be able to join in the analysis and use the original Xhosa-language transcripts would be 
the ideal situation, since then the idiom and nuances in the conversation could be included in 
analysis in more detail. 
Quantitative methods
Participants, sampling and statistical inference: Study IV
there were four main issues impacting on the quantitative study. Firstly, the lack of randomisation 
limits the causal inferences may be made. the advantage of using an interrupted time series study, 
however, is that it is the most robust quasi-experimental design available [108], since it counters 
secular trends and is strengthened by the inclusion of comparison clinics [166]. Poisson regression, 
which is suggested as an appropriate method of analysis [167], was used in this study.
in time series studies such as this one, data collected were from different time periods from the 
same sources, and therefore can be correlated. We controlled for this correlation in the analysis 
by using the gee approach. however, the causal inferences made from this study are also limited 
by the short time period after intervention, which prevents conclusions being drawn about the 
long-term effects. 
secondly, data quality and the way that it is entered could sometimes introduce information bias 
into the study. however, in study iv including patients from routine quality controlled registers 
that were collected and entered at a central point meant that the recording systems for patients 
at the different clinics were similar. therefore this would not have impacted on the results of 
the study. the checking of register data against clinic-held registers and folders also enhanced 
validity in this study, as the number of errors found was small. however, using register-based 
data meant that some useful variables were not captured, such as patients’ hiv status and whether 
they were taking aRvs concurrently with their tb medication. 
Thirdly, the outcome measurements for the time series study were based on the TB definitions 
used by the Who. patients were diagnosed as tb-positive either with Ziehl-nielson sputum 
microscopy, cultures, or clinically. Since diagnosing TB is more difficult in HIV-positive than 
in hiv-negative patients [7], not all tb patients in our study may have had tb. however, as 
our outcome for smear-negative patients was treatment completion, and the same approach was 
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applied across intervention and comparison sites, this did not affect the findings. The Cape Town 
central laboratory analysed all sputa from all clinics, and they have rigorous quality controls. 
Therefore sputum results were not verified at the laboratory. 
Fourthly, not knowing the hiv status of the patients may have impacted on outcome measurements. 
hiv-positive patients may be on concurrent aRt, and they may have more complicated treatment 
regimens and side-effects than patients with only tb. patients on aRt may also have attended 
treatment information sessions already, and may have to take more tablets daily. however, the 
HIV prevalence at intervention and comparison clinics did not differ considerably (between 68% 
and 73%). 
one of the differences between intervention and comparison sites was that four of the intervention 
sites and one of the comparison sites were co-located with clinics providing aRvs. however, 
hiv-positive people at the clinics not co-located with aRt sites would have been referred to 
another site if eligible for aRt.
Generalisability
the conceptual generalisability of studies i and ii is increased by the use of theoretical frameworks. 
Conceptual generalisability implies generating an understanding of issues in a certain setting, and 
applying the concept rather than the specific issue more generally [168]. For example, in Study 
II, although the specifics of the hierarchical relationship between nurses and lay health workers 
might not be applicable to all clinics, the idea that there might be a hierarchical relationship when 
engaging in a programme such as the eta could be extrapolated from this study. 
A similar application could be done for Study I, where the Kingdon framework [146] was used. 
in study iii, the concepts of change in lifestyles and challenges in terms of empowerment could 
be applied. however, as in qualitative research in general, these results are not intended to be 
generalized as being representative of all patients, lay health workers or nurses in south africa. 
study iv was an interrupted time-series study with comparison clinics. Randomization would 
have allowed for greater generalisability of results, since the specific characteristics of each clinic 
could not have impacted on the study results. since the clinics part of this study was pre-selected 
by the City of Cape town, they may not have been representative of the clinics within the Cape 
town area. therefore, the results of study iv should be interpreted with caution. however, the 
results could be applied to similar clinics with high hiv and tb co-infection within similar 
urban settings in south africa. 
fINDINGs 
this thesis focused on the development, implementation, and outcomes of a tb treatment 
intervention, the eta programme. the intervention was developed because key individuals 
in the health services were aware of the problems within the tb programme and of possible 
solutions, and because the political situation was amenable to change (study i). 
study ii examined implementation of the programme from the perspective of the normalization 
process model. The findings indicate that implementation of the ETA was influenced mainly 
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by human resource issues, including, among others, perceptions of the programme, attrition of 
health workers and training issues. study iii indicated that patients may have experienced their 
tb treatment more positively, were more inclined to take responsibility towards their treatment 
taking, and incorporated treatment taking into their daily routines, although there was little 
evidence of empowerment. 
Resource issues in terms of facilities and financial inputs also influenced implementation of the 
programme to a great degree. The time series study (Study IV) indicated small but significant 
improvements in smear conversion rates in intervention clinics after the intervention, relative to 
the comparison clinics. These findings are elaborated on in the section below. 
Influences on the decision to introduce a change to the TB programme 
Researchers have long searched for avenues through which research can influence policy [169, 
170], but empirical examples of this process - especially in low- to middle-income contexts, 
remain few [171]. Some of the empirical investigations available indicate that research influences 
policy in a diffuse manner [169]. There were also indications of this in Study I, which indicated 
that key individuals had a considerable contribution in bringing about the eta, as also noted in 
another study from sub-saharan africa [172] and in other contexts [173]. the key individuals 
who were part of the programme change were also aware of the research conducted on tb Dot, 
and had interacted with researchers and activists who were trying to promote a change. however, 
this interaction did not seem to directly influence the change from DOT to the ETA. Although 
interaction between researchers and policy makers is considered an important consideration in 
using evidence [173], this did not emerge as an important consideration in study i. 
Instead of research directly influencing the change from DOT to the ETA, the interaction of 
problems, solutions and the political environment together with key individuals, as postulated 
by Kingdon [146], seemed to influence the programme change to a greater degree. Although the 
study included few participants, the role of these well-placed individuals came through clearly 
from interviews. these individuals were also members of a committee that dealt simultaneously 
with hiv- related issues, tb-related issues and those related to managing sexually transmitted 
diseases. they were therefore aware of the need for a change, and potential strategies that could 
be effective. 
in the case of this study, then, it seems that integration initiatives at policy or managerial level 
might have translated into changes at community level after some time. this change seems 
to have necessitated the presence of “champions” to drive the change. Further investigation is 
needed to establish whether this also happens in other settings. 
Although it is likely that there was a multitude of factors influencing the change from DOT to 
the ETA in TB management in Cape Town, the impact of the impending ART roll-out is difficult 
to ignore here. south africa is planning to have 80% aRt coverage for those who need it by 
2011 [174]. early estimates based on the number of people living with hiv/aiDs in south 
Africa in 2005 suggest that over 2,6 million people would require ART by 2015 [175]. Most of 
these will come to the already overburdened primary health care system. therefore, there is a 
need to ensure that the primary health care system is strengthened, and that aRt provision will 
be integrated into the existing primary health care system [176, 177], along with other treatment 
programmes such as that for tb. 
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there have already been indications that health professionals may move to the better resourced 
aRt programme from other primary health care departments [75]. there is therefore an urgency 
to ensure that programmes remain functional, and wider use of community health workers [178] 
and task shifting in general [133] has been posited as one way of dealing with human resource 
problems in the context of aRt.  this situation therefore could have created additional pressure to 
try alternative approaches to the human resource-intensive Dot programme, especially in terms 
of professional staff, and may have motivated trying approaches that would enable integration 
with existing programmes. 
in the context of the human resource crisis and the aRt roll-out, and the high rates of tb and 
hiv co-infection, integrating tb treatment and aRt makes logical sense. however, Dot once 
a day for all those patients taking tb treatment and eventually for all those patients taking aRvs 
seems a large burden on health services. 
transferring the role of observation from health services to a family member seems like an 
option to reduce some of the burden. however, it is possible that family members could in some 
cases not provide support at all, as found in study iii, or in some cases not observe treatment 
but support and motivate the patient, as is the intention in the eta. therefore, this would not 
constitute Dot but a supportive approach such as that intended in the eta. in addition, having 
families support the patient during treatment should also not absolve the health care system from 
responsibility for the patient’s treatment course [43], and health care systems would be expected 
to continue providing support and education to patients. 
Influences on implementing the ETA
study ii suggested that the dedicated project manager employed with the assistance of additional 
financial resources assisted staff in implementing the programme, and it is possible that she 
enabled the programme to maintain outcomes. this corresponds with the recognized importance 
of mentoring and supervision for health care staff [179]. it would be interesting to discover 
whether providing similar close supervision to the control sites would also result in improvements 
in treatment outcomes. 
When nurses and treatment supporters were being supported in their work, and they knew their 
outcomes were closely monitored, they could have been more motivated and could have put 
more effort into their work. in addition, it seemed that there was a real drive and a wish for the 
programme to work, and for it to be rolled out elsewhere, especially on the part of treatment 
supporters and adherence counsellors. 
a number of issues also hampered implementation. the programme experienced high levels of 
treatment supporter attrition. attrition of lay health workers is a common problem in community-
based programmes [180], and was therefore to be expected. a number of disincentives for 
community health workers have been suggested, such as inconsistent payment, inequitable 
distribution of incentives between different community health workers, inadequate supervision 
and lack of respect from health facility staff [180]. 
We discovered in the data analysed for study ii that there seemed to be two main contributors to 
attrition in the eta: a hierarchical working relationship where treatment supporters were lowest 
in the pecking order and were perceived to have low status, and delayed and low stipends. 
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Problems in teamwork [136] and tensions between lay health workers and professional nurses 
[133] are well documented elsewhere. in addition, all lay health workers also encountered issues 
unrelated to tb in their work, in particular issues related to hiv, although there was no direct 
evidence that this contributed to attrition. treatment supporters also faced challenges, such as 
drug and alcohol abuse, when working in the community. these may have made their work 
more demanding than envisaged by programme managers, and could also have contributed to 
attrition. 
the solution to lay health worker attrition is not simple, and would require more detailed 
investigation, especially if lay health workers are to be depended on to provide a wider range of 
health tasks in the community. it did appear that in some of the participating clinics, treatment 
supporters were more likely to stay in the programme despite a number of complaints and 
problems with payment. some of the reasons for this could include that the treatment supporters 
in this clinic had been part of tb treatment there for a long time, whereas the other clinics had 
more new members, and that the clinic was known in the area for having a good team spirit, had 
had considerable investments in infrastructure, and was frequently referred to as a model site. 
one of the likely causes of attrition - problems in teamwork and hierarchical working 
relationships - is difficult to correct. Staff were offered teambuilding for one day which, while 
perhaps contributing positively to teamwork, may be too little to prevent teamwork problems 
in day-to-day work. however, additional training might contribute towards improving working 
relationships at the clinic. In this study training seemed to influence both relationships between 
staff and attitudes towards the programme. however, the duration of training was very short, 
especially for nursing staff, who only received one day of training in addition to clinic-based 
support. 
another aspect of training was that staff at times doubted lay health workers’ skills, which may 
have in turn contributed to difficulties in relationships between staff members, and thus possibly 
to lay health worker attrition. however, staff had been given clear roles and tasks, which may 
have facilitated implementation and prevented major territorial conflicts.
attitude changes, which would be necessary when shifting the approach from Dot to a more 
empowering approach, are unlikely to be achieved in one day, and support at the clinic centred 
mainly on administrative forms and implementing the programme.  Changes in the behaviour of 
health care professionals do not always happen automatically [152]. these may also be hampered 
by nurses being rushed and overloaded with work in overcrowded and chaotic clinics [136]. 
making a change in working patterns is therefore likely to take time and effort, which may be in 
short supply at the clinic, but also in the management level of south african health care systems, 
which would be expected to facilitate this change. 
another major stumbling block to the new programme was the available facilities. similarly 
to findings in a study focusing on prevention of mother to child transmission services in South 
africa [181], lack of infrastructure in terms of counselling rooms was a major challenge in the 
programme. When adherence counsellors had to counsel in shared rooms, confidentiality could 
be breached, or this could make patients uncomfortable, which could in turn lessen intervention 
effects. in addition, treatment supporters interpreted the lack of space allocated to them as an 
indication that they were not officially part of the clinic. 
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implementing new programmes would therefore require arranging dedicated space for new 
members of the team, even if this were a structure in the clinic grounds. Rolling out this 
programme on a wider scale would also necessitate taking care of other logistical challenges, 
such as ensuring a steady stipend for lay health workers. 
Impacts of the EtA on patients’ experiences of tb treatment 
The study findings suggest that the ETA may have had a positive impact on some patients’ 
experiences of tb treatment. Whether the eta was empowering, however, is an interesting 
issue, which is discussed in more detail below. 
empowerment of patients is part of the stop tb strategy [34], and was presented as a central 
concept to staff implementing the programme. however, empowerment is a broad concept 
that encompasses more than just the provider-patient relationship or treatment taking [12]. 
empowerment also needs to be sought by people and not given to them by others [182]. in 
addition, empowering programmes need to be so from the beginning [12]; and while the approach 
used in the eta was intended to be empowering, the methods and problems were implemented 
‘top-down’, and according to data not included in the articles, little consultation was undertaken 
prior to implementation at community or clinic level. 
the change to the eta from Dot therefore could be seen as a more semantic change than a 
practical change, at least for adherence counsellors and professional nurses. some of the study 
sites had already implemented unofficial self-supervision due to human resource constraints, by 
providing patients with weekly supplies of tablets. For lay health workers, the eta required more 
administration and walking in the community, which was a large change in practice. however, 
it is possible that they perceived their relationship with the patient as not having changed at all. 
it is possible that this is one of the reasons why (as found in study ii) staff did not change their 
approach considerably, since the eta did not represent a large change in their day-to-day work. 
it is possible that although the eta was presented in terms of empowerment, it was not truly 
an empowering programme. there may be many reasons for this, and one of these may include 
that the programme was envisaged and implemented from the health services’ perspective rather 
than from the community perspective. it is also possible that the Dot ethos of supervision 
was transferred to patients and their treatment buddies in counselling sessions, or in discussions 
with the treatment supporters. there is limited information on what adherence counsellors told 
patients and their buddies in counselling sessions. 
however, reports in steering groups suggested that each counselling session was approximately 
20 minutes in duration. it is likely that this time did not allow for an in-depth discussion of the 
information presented, or much time for patients to present their views on treatment and thus may 
not have been empowering. in addition, some patients in study iii indicated that buddies had 
begun supervising the patients’ treatment taking. this issue would need further investigation.  
although questions can be raised about the content of the counselling sessions in this study, 
tb nurses also have to undertake many tasks in a short period of time when receiving a tb 
patient, and this may result in pressure and little time for interaction or for sharing information. 
having separate adherence counsellors may therefore be helpful. sharing information could 
be seen as part of the process of empowerment [102]. in addition to empowering patients, 
50
sharing information could result in better provider-patient interaction, which has been found to 
influence patients’ treatment adherence [16]. The involvement of a separate counsellor to provide 
information and knowledge about tb and its treatment therefore gives the patient the knowledge 
about treatment and its effects that they have asked for [43]. adding this counselling element 
to tb treatment may help patients to understand the treatment requirements and contribute to 
empowering patients to take greater control over their own health. 
Despite the above questions about the empowerment approach used in the programme, and 
empowerment being a long-term process [12] and requiring a longer time period and measurement, 
there were some indications that patients may be more ready to take control over their own 
treatment taking. some patients had also incorporated treatment into their daily routines. it is 
possible that they were repeating information they had heard in counselling sessions. however, 
in contrast to patients in clinics implementing the eta, patients from comparison groups spoke 
of taking control over their treatment from treatment supporters. this suggested that they were 
not only feeling inconvenienced by having to visit treatment supporters [16], but also felt 
disempowered by this requirement. 
Taking TB treatment into the community
the inconvenience of attending daily Dot is also cited as one of the reasons for poor adherence 
[16]. This requirement was removed in the ETA, and therefore patients had to take fewer trips to 
the clinic. in return for this reprieve from frequent clinic and community visits, however, they 
had to receive treatment supporters at their homes. not all patients had trusted the treatment 
supporters’ intentions initially, similarly to findings in similar contexts that indicate that treatment 
supporters had to negotiate their entry into the home [183]. this may be related to stigma about 
tb and hiv, which is very prevalent in these communities and in other settings with high hiv 
and tb prevalence [184]. 
treatment supporters had a key role in the programme, and it is unlikely that their work would be 
lessened in future tb programmes. however, keeping this aspect of tb treatment would require 
investigating how treatment supporters could be better received by patients. Facilitating treatment 
supporter entry into the home is not a simple process; although name badges including the clinic 
name might allow for entry, at the same time it risks stigmatising the patient and identifying them 
as a tb patient, which may in turn result in the patient being labelled as hiv positive. 
although treatment supporters visiting the home could be seen as continued monitoring of the 
patient, and extending surveillance from the clinic to the community [185], it can also have 
benefits. Having treatment supporters visit the home allowed for identifying HIV-positive 
contacts, children and those who exhibited tb symptoms, although this aspect could not be 
investigated in this study. In contrast the DOTS system depends on passive case finding – on 
patients coming to the clinic presenting with symptoms. Active case finding has been suggested 
as an effective method for identifying tb cases and reducing mortality, for example in india 
[186]. The form of active case finding used in the ETA, by having treatment supporters visit the 
home and identifying tb contacts, may assist in reducing the burden of tb in the community, 
and further attention should be paid to its processes and impacts. 
Empowerment in the ETA in relation to wider society
one of the more general issues related to the lack of evidence of empowerment is that patients 
were not part of any wider social movement or support group, as is the case for aRt patients. 
these groups have been found a key component of empowerment [12]. aRt patients have peer 
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support groups, which may assist in them becoming more empowered; and are supported by the 
larger movement to find their own voices in the struggle to gain access to treatment [77]. 
although to date tb patients have had no need to demand treatment, peer support groups could 
be considered as an addendum to the eta approach and one way to increase empowerment. 
These groups have been found to be beneficial for adherence in Ethiopia [187], and patients’ 
responses in FgDs suggested that they might appreciate an opportunity to share their treatment 
experiences. Despite the limitations in empowering patients, the programme was well received 
by patients and thus may present a less paternalistic alternative to tb treatment than Dot.
empowering patients would necessitate taking into account the wider community and wider 
society. the tb patients in this study were mainly from the most disadvantaged part of south 
african society, and may also not be empowered in other spheres of their life. therefore, efforts of 
empowerment in a tb programme may not translate into effects in the patients’ lives in general, 
and the attempts within tb programmes may also be countered by the disempowerment faced 
by patients in their daily lives. 
in addition, changes in the tb treatment programme may not be able to counter the nature of 
the public health system in general. both the public health care system and the tb care system 
[136] could be structured in such a manner that they may not facilitate an empowering approach 
to patients. the public health care system in general could be considered as technocratic and 
‘top-down’ [188] and as containing inherent power differentials. the working relationships 
within public health nursing have been found to be hierarchical, and containing differences in 
power within the hierarchy [189]. similarly, there remain power differences between nurses and 
lay health workers, and nurses find it difficult to accept lay health workers as partners in care 
[190]. it therefore could be expected that the relationships between health care professionals and 
patients also contain a dimension of power and inequality. 
treatment outcomes of the EtA
The significant difference in improvement of smear conversion rates at 2 months between the 
intervention and comparison clinics is, however, promising. this suggests that at least initially, 
patients were arriving for their sputum tests, and had taken their treatment. Despite this, there was 
no significant difference in treatment success and cure rates between the clinics implementing 
the eta and comparison clinics. Rates of default also remained higher than the international 
average [36]. 
improved sputum conversion rates are a positive impact of this intervention. it suggests that 
patients may have been more adherent, and could suggest that more patients are now less 
infectious - and therefore less likely to spread infection in the community [191]. it is possible 
that the lack of impact at the end of treatment is due to the diminished support during the last 
4 months of treatment. it is not clear which processes of the intervention resulted in improved 
sputum conversion rates. it is also possible that treatment supporters reminded the patients to 
come for their sputum tests while visiting; but it is also possible that patients were now more 
aware of the importance of keeping appointments due to the counselling, or that they had truly 
been adhering better and therefore felt more confident in coming for testing. 
patient education and counselling is a key step in ensuring that patients understand treatment 
requirements [192], and may also contribute to adherence to treatment. therefore the impact of 
counselling is an area that needs further investigation. 
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the settings in which this study was conducted are also highly mobile. the pattern of labour 
migration is well established in south africa, with rural dwellers travelling between the city 
and their home to make their living in cities. this pattern has also been found to result in a high 
burden of disease in rural areas from where people originate, and the cities in which they work 
[193]. it is likely that many of the patients in this study travelled home to rural south africa to 
attend funerals or other important family events. they may also have taken up residence with 
their family close to the study clinics when ill, and returned to their own homes when they felt 
better. the advantage of the eta in this situation is that patients can have their monthly treatment 
supply with them and do not need to attend a clinic in the rural areas, to which there may be a 
considerable distance to travel. 
the mobility of these settings is also a challenge to adherence rates, as found also in aRt 
treatment [93], since many patients may not be able to take their treatment as they have travelled 
away and sometimes may not have sufficient money to return to Cape Town for treatment, even 
if they wanted to do so. 
Although not all results in this study were significant, it seems that treatment outcomes in ETA 
clinics maintained their pre-intervention levels or continued to increase. this suggests, as in 
other studies before this [41], that providing tb treatment can be done in other ways besides 
through daily DOT. While DOT has been found to be beneficial for certain groups of patients 
who may already lack agency, such as prison inmates [64], it is not necessarily an approach that 
should be implemented for all tb patients. it is likely that some patients are motivated by their 
family or other reasons to complete treatment [194], and may not need to be observed taking 
their treatment every day. one of the reasons for the staying power of Dot could be the lack of 
a reliable, established alternative. 
although this research cannot conclusively suggest that the eta is equivalent to or better than 
Dot, it is a promising approach that should be evaluated further. 
given that the results are promising, the potential of rolling out the programme should be 
discussed. Considerable management and logistical challenges that fall outside the aims of this 
thesis remain, and are reported in more detail elsewhere [195]. Despite these, the programme 
does hold promise in the development of an integrated approach where patients infected with 
both hiv and tb could receive treatment. 
this study also offers support for the calls for integrated tb and hiv treatment. the challenges 
to treatment supporters and adherence counsellors in encountering issues beyond tb while 
counselling, as found in study ii, suggest that patients indeed do not compartmentalise their 
diseases [73], but would prefer to receive information and treatment for both diseases (tb and 
hiv) at the same time. having one community health worker responsible for both treatments 
would be more efficient in terms of human resource allocation, and might also place less pressure 
on the patient in terms of welcoming a number of different people into their homes or having 
to travel to different locations in the community. having one community health worker might 
also be beneficial to the patient-treatment supporter relationship, if the treatment supporter could 
respond to the patient’s concerns regarding more than one medical issue. 
Further research should focus on whether an approach such as this would be sustainable, 
and whether treatment supporters would have the capacity to deliver combined aRt and tb 
services.
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concLusions
This thesis aimed to examine the ETA programme, which was implemented in five primary 
health care tb clinics in Cape town, south africa. this thesis explored the development of the 
ETA programme in order to generate information for those seeking to influence agenda setting 
for policy making. in addition, the implementation of the programme from a staff perspective 
and the impact of the eta on patients’ experiences of tb treatment were explored. the eta’s 
impact on tb treatment outcomes was also measured. 
the results suggest that the eta is a feasible approach, although challenges remain in 
implementation, and that it is an approach that is acceptable to patients. the main conclusions 
that can be drawn from this study are the following:
•	 programme changes, such as the eta programme, come about through the interaction 
of a number of factors, but are driven by key individuals with access to information and 
resources (study i).
•	 the eta was developed partly in order to address human resource issues, but its 
implementation was also constrained by these, in particular problems with teamwork, 
staff attrition and lack of training. having a dedicated project manager was integral to 
programme implementation (study ii).
•	 patients who were enrolled in the eta seemed to have incorporated treatment into their 
daily routines, and seemed to have embraced the idea of taking control over their own 
treatment taking (study iiI). however, empowerment did not seem evident in patient 
reports or in staff attitudes towards patients (studies ii and iii).
•	 patients had varying responses to treatment supporters visiting their home, and more 
attention should be paid to how treatment supporters gain access to patient homes, 
especially in the context of hiv (studies ii and iii).
•	 buddies had a range of roles in supporting their patient in treatment, from providing 
valued support to observing each treatment dose taken (study iii).
•	 The ETA had modest positive effects on smear conversion, but there was no significant 
difference in treatment outcomes (study iv). 
•	 the eta holds promise for tb and hiv treatment integration, and staff experiences 
support the need for this integration (studies ii and iv).
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POlICy IMPlICAtIONs AND RECOMMENDAtIONs
this study has shown that an approach that differs from Dot can be acceptable to patients, and 
can be implemented by clinic staff. treatment outcomes in both intervention and comparison 
clinics continued to increase, and there was no significant difference in outcomes between the two. 
therefore, wider implementation and testing of this approach in different settings in south africa, 
and possibly in similar settings outside south africa, could be encouraged. 
if treatment outcomes are maintained in participating clinics, policy makers could consider 
incorporating aRt with the eta. this more integrated approach might reduce duplication of 
human resources.  Rolling out the programme on a larger scale should be carefully evaluated. 
implementing this programme at other clinics would also require solving some of the logistical 
issues that emerged during this evaluation, which include, among others:
•	 ensuring a private, confidential place for adherence counsellors to counsel patients; 
•	 ensuring a steady payment schedule of stipends for lay health workers;
•	 addressing other issues related to lay health worker attrition and focusing on retaining 
those already part of the system;
•	 investing in training and on-site supervision of staff implementing the programme; and
•	 paying attention to issues of teamwork, hierarchy, and teambuilding among staff involved 
in the programme.
Further studies should be conducted on how programmes such as these could be embedded into 
routine practice, and how the dedicated staff for these programmes could be retained, without their 
time being pulled into other crises that need handling at primary health care clinics. this study also 
offers support to the need for mentoring and supervision in primary health care clinics in south 
africa. 
Further investigations could also be made of how treatment supporters and adherence counsellors 
implement this programme, and of how tb patients could become more empowered and have 
more equal interactions with the health care system in south africa. Community-based support 
groups could be one avenue through which this could be explored. 
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APPendix 1: 
Interview guide for programme planners, Study I
Why did the intervention start? (or: What were the main reasons for initiating the 
intervention?)
in your opinion, what motivated the need for a new tb adherence intervention?
how did this intervention begin? What was the original idea? What did you see as the key 
objectives?
What and who drove the intervention towards implementation?
to what extent was the community or other stakeholders (health providers etc) consulted in the 
process? Were their views taken into account in some way?
Who were the main actors who drove the project to implementation? Were there particular 
“champions” for the project? how did they succeed in driving the project?
What drives the project/ what motivates people to try out this project?
How does the programme work? 
What, in your view, are the key elements of the programme? how will it effect change?
Do you believe that this programme will make a change to tuberculosis treatment outcomes? if 
yes, how? if no, why not? 
What are the particular aspects of the programme that will improve outcomes and how?
if you were to explain to someone how this programme works, what would you say? 
on what aspects of the tb treatment does this programme focus on (most/least)? 
What are the successes and challenges thus far?
What, in your view, are the successes of this programme to date? What do you think has helped 
implementation?
What, in your view, are the challenges of this programme? What do you think has hindered 
implementation?
in your view, how has the programme impacted on relations between nurses and patients? how has 
it impacted on relations between treatment supporters and patients?
if you were to design the programme again, is there anything you would do differently?
When implementing the programme on a wider scale, is there anything you would change?
is there anything else you would like to add that we have not covered in this interview? 
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APPendix 2: 
Adherence counsellor interview guide example
Please tell me about the working environment in the clinic:
Do you have good relationships with staff?
prompt: 1. programme managers, 2. treatment supporters, 3. tb nurses, 4. other adherence 
counselors?
have you experienced any problems with staff?
how were these resolved? by whom?
Do you find your work environment helpful to your work?
Prompt: supplies, space, confidentiality
are you concerned about mDR or XDR tb?
if yes, how do you deal with this?
Do you have any other duties at the clinic besides your counselling work?
Please tell me about your counselling
Do you think the way you counsel patients has changed since you started counselling?
if yes, how?
how do you go about a counselling session?
Do you patients ask questions that you were not taught in training? What are these?
have you become more familiar with issues related to disseminated tb?
have you become more familiar with issues related to hiv/aiDs?
Would you change anything about the counselling?
Please tell me about patient response.
how do patients respond to counselling? 
are there differences in response between people (e.g. do some people respond better than 
others)?
prompt: gender, age, etc.
Now I would like to talk about the programme in general
now that you have been part of the programme for a long time, would you change anything 
about it?
What do you like the least about the programme?
What do you like the most?
is there anything else we have not talked about that would be important for others to know about 
your work?
if someone was considering doing this programme at another clinic, what would you tell them 
about it?
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APPendix 3: 
Patient focus group guide example
All of you have been on TB treatment. We are now trying to find out what you think of the 
treatment, and how it could be improved. 
Start each group by asking each person to share with the group their response to the following 
question:
- what was the most important event during your tb treatment?
Clinic experience:
When you first arrive in the clinic and you are told that you have TB, how do you feel?
how are you treated by clinic staff
- prompt: tb nurse, adherence counselor, treatment supporter, others
Do you have any problems when you arrive at the clinic? 
- prompt: what are these?
General experience:
Could you tell me, what was it like to be on TB treatment first?
What was it like after a couple of months?
What is it like now?
how does being on tb treatment affect your daily life?
What kind of problems have you experienced with taking treatment?
What has helped you in taking your treatment?
- Who supported you in your treatment?
Why do you think people don’t complete their tb treatment?
What did you think is needed to support people to complete their treatment?
Experience of counseling
before you took your treatment at home, you attended some counseling sessions.
What did you think of these?
 - how did it change the way you thought about tb?
What was the counselor like?
Do you think it prepared you for taking your tb treatment?
 - prompt: why?
What did you think of the flipchart that was used?
- prompt: information, pictures
Experience of treatment supporter
each of you were assigned with a treatment supporter, who did a home assessment and then visited you. 
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How did you feel when the treatment supporter visited you for the first time?
how was your relationship with the treatment supporter in the beginning? 
What was it like in the middle of the treatment?
What is it like now?
how often did they come to see you?
What kind of issues do you discuss with your treatment supporter?
What kind of issues do you not discuss with him or her?
What do you like most about the treatment supporter?
What do you like the least about him or her?
if a friend of yours had hiv and tb, do you think they would like to have 
a treatment supporter visiting their home?
if yes, why? if no, why?
Buddies
You also were asked to have a buddy to support you in treatment.
What did the buddy do to support you?
Was having a buddy helpful to you?
- prompt: if yes, how? if no,why not?
Did your buddy know about tb? if yes, how? (prompt: had they had tb before?)
General experience
if you could change anything about tb treatment, what would you change?
if a patient had tb, would you tell them to come to this clinic?
if yes, why?
if no, why not?
is there anything else you would like to mention about tb treatment that we have 
not mentioned before?
how have you found talking about these issues in a group?
Thank you!
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